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ABSTRACT 
Platinum is the metal present in various classes of inorganic medicinal agents directed at 
important diseases such as cancer or viral infections.  Several new Pt(II) complexes of polyamine 
ligands bearing a dansyl moiety linked by a sulfonamide group were prepared; in some cases the 
sulfonamide nitrogen formed a bond to Pt.  The sulfonamido group donates strongly to Pt and 
places the dansyl group close to a vacant coordination position, allowing it to stack with bound 
guanine base (G) when G binds.  The emission of the fluorophore decreases with decreasing 
distance to Pt.  
Metal nuclide radiopharmaceuticals contain a metal core and an inner ligating unit, 
usually having chelate rings.  The development of the advantageous fac-[99mTc(CO)3(H2O)3]+ 
precursor has opened new directions for radiolabeling.  The non-radioactive fac-
[Re(CO)3(H2O)3]+ analogue is useful in understanding the chemistry of agents derived from the 
[99mTc(CO)3(H2O)3]+ species.  To achieve a net neutral coordination unit in radiopharmaceuticals 
with a fac-M(CO)3+ core (M = Tc, Re), facially coordinated monoanionic tridentate ligands (L¯) 
are needed.  Several fac-[Re(CO)3L] complexes containing the sulfonamido group as one 
terminal ligating group were synthesized and characterized by X-ray crystallography and NMR 
spectroscopy.  For most sulfonamido complexes studied here, the two chelate rings have 
different pucker chirality, as is commonly found for a broad range of metal complexes. The 
complexes are stable at neutral and basic pH values and thus have potential for providing a 
neutral label in radiopharmaceuticals.  The NMR signal averaging indicates that the rotations 
about the N−S and S−C bonds of the sulfonamido group are rapid on the NMR time scale. 
Understanding the chemical features of the prototypical complexes by using the fac-
[Re(CO)3L]-analogue approach and the minimal ligand was the goal of this part of this 
investigation.  fac-[Re(CO)3L]+ complexes containing prototypical NNN or NSN tridentate 
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ligands, such as diethylenetriamine (dien) and simple dien derivatives, were investigated by X-
ray crystallographic and NMR methods.  fac-[Re(CO)3L]+ complexes with two terminal exo-NH 
groups exhibit unusually upfield exo-NH NMR signals, which shift downfield on addition of Cl¯ 
indicating 1:1 ion pairs forms involving one Cl¯ to two exo-NH's H-bonds.  
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CHAPTER 1. INTRODUCTION 
Inorganic compounds have found extensive usage as chemotherapeutic agents.1 Examples 
include the anticancer agent cisplatin (cis-[Pt(NH3)2Cl2]), the gold-containing antiarthritic drug 
Auranofin, gadolinium compounds used as magnetic resonance imaging-enhancing agents and 
99m-technetium compounds used as radiopharmaceuticals in disease diagnosis.2  
1.1 cis-[Pt(NH3)2Cl2]  
Platinum anticancer compounds are probably the most studied inorganic drugs in history 
and that because cisplatin is the only anticancer agent known to cure a malignancy.2-4 Cisplatin is 
used to treat a variety of cancers, such as head, neck, lung and bladder cancer.3,5 Upon entrance 
to the cell, the cisplatin chloro ligands are displaced by water. Water is a good leaving group, and 
therefore an aqua cation formed by cisplatin is thought to be the reactive form in vivo. Within the 
cell, cisplatin interacts with a number of biomolecules such as peptides (glutathione), proteins 
and nucleic acids. Eventually though, it is well established that the final target of cisplatin is the 
N7 of guanine bases of DNA.3,5 Binding causes the DNA strand to bend by an angle of ~40-50°. 
Interaction of the platinated DNA with cellular proteins, particularly high mobility group domain 
proteins, increase the bending of the helix and possibly prevent repair by the DNA-repair 
proteins, thus preventing replication and eventually causing cell death.3 
Platinum is present in various classes of metal-containing medicinal agents directed at 
important diseases such as cancer or viral infections.3,4,6,7 The high affinity toward the N7 of 
purines, particularly guanine, in nucleic acids4,8 is a key feature of the Pt(II) center that may be 
an important property endowing Pt(II) agents with these valuable types of biological activity. 
Platinum drugs are clearly among the most efficious drugs active against a broad range of 
cancers.3 Pt drugs would find wider use except for the well-known toxicity generally attributed 
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to the reaction of the Pt drugs with the sulfur atoms in biological thiols and thioethers, such as 
cysteine and methionine residues.9 Thus, it is an important goal to identify features that reduce S 
binding while maintaining N7 binding. 
1.2 fac-[M(CO)3(H2O)3]+ (M = Tc or Re) 
Radiopharmaceuticals compounds, containing a radionuclide, are used widely for the 
diagnosis or therapy of various diseases. Metalloradiopharmaceuticals contain a metal core and 
an inner ligating unit (usually having chelate rings).  We refer to the core and inner ligating unit 
as a label. The important properties of the label, which influence biological behavior, are charge 
and overall shape. Technetium-99m (99mTc) is the radionuclide that is most widely used in 
diagnostic nuclear medicine.10-13 {99mTc(V)O}3+ has been the metal core used most 
predominantly. [99mTcO(MAG3)]2- (MAG3 = penta-anionic form of mercaptoacetyltriglycine in 
which the mercapto, amide and carboxyl groups are deprotonated) is the most widely used renal 
radiopharmaceuticals based on the {99mTc(V)O}3+ core. 
Radiopharmaceuticals based on the fac-[99mTc(CO)3]+ core are gaining extensive use 
because the fac-[99mTc(CO)3(H2O)3]+ precursor can be conveniently generated.14-17  Schibli et al. 
showed that agents with the fac-99mTc(I)(CO)3+ core bearing a tridentate coordinated ligand are 
more robust and have better pharmacokinetic profiles than agents bearing bidentate ligands.18 A 
recent straightforward preparation of aqueous solutions of the non-radioactive fac-
[Re(CO)3(H2O)3]+ precursor19 has made the synthesis of fac-[Re(CO)3L] analogues convenient 
and allows simulation of the aqueous 99mTc synthetic chemistry.19,20   
Commonly employed chelating ligands (e.g., diethylenetriamine (dien),21 cysteine- and 
homocysteine-based ligands19,20) contain N, O, or S donor atoms in groups such as carboxyls,22 
amines,23-29 nitrogen heterocycles,24-26 and thioethers.19,20,26,27 Extensively characterized fac-
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[Re(CO)3L] complexes of a series of symmetric and non-symmetric NNN or NSN ligands 
containing combinations of amine, pyrazolyl, and thioether donors are known.25-27 During the 
development of radiopharmaceutical renal agents, polyamino-polycarboxylic acid ligands have 
been investigated.23,30 At high pH amine group coordination is preferred, allowing for dangling 
carboxyl groups, which are important in high renal clearance.23,30 Other studies involving 
nitrogen, sulfur and oxygen donors have proposed that nitrogen donor ligands are better than 
sulfur donor ligands for the fac-[Re(CO)3L] complex formation.31,32 The 99mTc-tagged 
lanthionine agents were the first small fac-[99mTc(CO)3L] agents reported to have been evaluated 
in humans;33 thus, additional studies directed at gaining a more comprehensive assessment of 
conformation are warranted. 
An important approach in the development of small (~5 kDa) metal nuclide 
radiopharmaceuticals is the bioconjugation of a net neutral label to hormones, small peptides, 
etc.34 For fac-99mTc(I)(CO)3+ agents, the ligand(s) occupying the three remaining coordination 
sites must have one negative group close to the metal for net neutrality. A coordinated 
carboxylate group provides such a unit, but it does not provide a point for ligand elaboration or 
for bioconjugation. Consequently, there is a need to evaluate other groups within tridentate 
monoanionic ligands.  
1.3 Sulfonamide Ligands 
 Even though the sulfonamide group has been used extensively as a linking group in 
organic chemistry, it is in general a neglected ligand donor group for metal complexes. It has 
been shown that sulfonamide ligands bind well to several metals 35-40 but compared to other 
nitrogen-bearing ligands, reports of metal complexes of sulfonamide ligands are few. Even 
though, there are some reports of Pt(II) sulfonamido complexes41-43 none of them investigated 
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reactions with biomolecules. In the first part of this study, we prepared Pt(II) complexes of NNN 
tridentate ligands which have a sulfonamide linkage to a fluorescent group.39 These compounds 
presented us with the opportunity to investigate the effect of the fluorophore on the fluorescence 
and the properties of complexes with small biomolecules and to indentify the effect of the 
sulfonamido group on the selectivity of S vs. N7 binding.39 To our knowledge, the Tc(I) and 
Re(I) complexes of sulfonamido ligands have never been studied. As a prelude to 
radiopharmaceutical studies, we analyzed a series of new neutral Re(CO)3L complexes 
containing sulfonamide ligands which bind in a tridentate fashion involving one nitrogen of a 
monoanionic deprotonated sulfonamido group.44 
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CHAPTER 2. THE NEGLECTED Pt−N(SULFONAMIDO) BOND IN PLATINUM 
CHEMISTRY. NEW FLUOROPHORE-CONTAINING PLATINUM COMPLEXES 
USEFUL FOR ASSESSING PLATINUM INTERACTIONS WITH BIOMOLECULES* 
2.1 Introduction  
Platinum is the metal present in various classes of inorganic medicinal agents directed at 
important diseases such as cancer or viral infections.1-4  An important feature of the Pt(II) center 
that may be a key property endowing Pt(II) agents with these important types of activity is the 
high affinity toward the N7 of purines, particularly guanine, in nucleic acids.2,5 Platinum drugs 
are perhaps the best single type of anticancer drug active against a broad range of cancers.1 Pt 
drugs would find wider use except for the well-known toxicity resulting from the reaction of the 
drugs with biological thiols and thioethers.6 Thus, it is highly desirable to identify features that 
reduce S binding while maintaining N7 binding. 
Reactions of the monofunctional complex, [Pt(dien)Cl]Cl (dien = diethylenetriamine), 
with nucleotides have been studied extensively as an aid in assessing the nature of DNA binding 
of difunctional Pt(II) anticancer drugs (e.g., cisplatin).2,7  A study of the reaction rates of 
[Pt(dien)Cl]Cl with 5′-GMP (5′-GMP = 5′-guanosine monophosphate) and peptides [glutathione 
(GSH) and S-methylglutathione (GSMe) as models for cysteine and L-methionine (met) binding 
sites, respectively] showed that the Pt−sulfur bond is formed much more rapidly than the Pt−N7 
bond.6 Several other studies, including competitive reactions of [Pt(dien)Cl]Cl with met and 5′-
GMP (revealing that the kinetic product was Pt(dien)(met) and that the thermodynamic product 
was Pt(dien)(5′-GMP)), all indicate the same trend.8-10 
                                                 
* Reproduced with permission from American Chemical Society: Christoforou, A. M., Marzilli, 
P. A., Marzilli, L. G., “The Neglected Pt−N(sulfonamido) Bond in Pt Chemistry. New 
Fluorophore-Containing Pt(II) Complexes Useful for Assessing Pt(II) Interactions with 
Biomolecules,” Inorganic Chemistry, 2006, 45, 6771-6781. Copyright 2006 American Chemical 
Society. 
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Many Pt(II) complexes with ligands having the dien backbone have been synthesized and 
studied, e.g., N,N′,N′′-trimethyldiethylenetriamine (N-Me3dien), N,N,N′,N′′,N′′-
pentamethyldiethylenetriamine (N-Me5dien), and N,N,N'',N''-tetramethyldiethylenetriamine (N-
Me4dien).11-13 Preferential binding of  [Pt(N-Me4dien)Cl]Cl to the sulfur of glutathione and the 
absence of binding to an imidazole nitrogen of histidine was attributed to steric effects.13  
 
 
Figure 2.1. Fluorescent ligands used in this study. 
  
In this study, we explore the chemistry of complexes with tridentate ligands bearing a 
sulfonamide and an aromatic fluorescent group. The ligands (Figure 2.1) used in this study are 
N-(2-((2-aminoethyl)amino)ethyl)-5-(dimethylamino)naphthalene-1-sulfonamide (DNSH-dienH, 
where DNSH = 5-(dimethylamino)naphthalene-1-sulfonamide) and N-(2-(bis(2-
aminoethyl)amino)ethyl)-5-(dimethylamino)naphthalene-1-sulfonamide (DNSH-tren, where tren 
= tris(2-aminoethyl)amine). (The H indicates protons displaceable upon Pt binding, i.e., the 
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sulfonamide NH for the dienH moiety and the H8 for the DNSH moiety). The DNSH-dienH 
ligand afforded the Pt(DNSH-dienH)Cl2, Pt(DNSH-dien)X (X = Cl, Br), and Pt(DNS-dien) 
complexes, whereas DNSH-tren gave [Pt(DNSH-tren)Cl]Cl (Figure 2.2). These compounds 
presented us with the opportunity to investigate the effect of the fluorophore and the properties 
of complexes with small biomolecules such as 9-substituted derivatives of guanine (G) or of 
hypoxanthine (3′-inosine monophosphate, 3′-IMP).  
 
 
Figure 2.2. Pt(II) complexes synthesized in this study: Pt(DNSH-dienH)Cl2 (1), Pt(DNSH-
dien)Cl (2), Pt(DNSH-dien)Br (3), Pt(DNS-dien) (4), and [Pt(DNSH-tren)Cl]Cl (5). 
 
 10
2.2 Experimental Section 
2.2.1 Starting Materials   
Tren from Strem, N′-Me-dien (N′-Me-dien = N-methyl-2,2′-diaminodiethylamine) from 
TCI America, Pt(en)Cl2, N-Et-en = N-ethylethylenediamine and dien from Aldrich, and the 
following materials from Sigma: dansyl chloride (DNSH-Cl), 9-ethylguanine (9-EtG), and the 
sodium salts of 3′-guanosine monophosphate (3′-GMP), 5′-GMP, 5′-guanosine diphosphate (5′-
GDP), 5′-guanosine triphosphate (5′-GTP), 3′-IMP, and met were all used as received.  The 
DNSH-dienH and DNSH-tren ligands were prepared by known methods,14,15 and their 1H NMR 
chemical shifts matched the reported values.  Cis-Pt(Me2SO)2Cl2,16 cis-Pt(Me2SO)2Br2,17 
[Pt(dien)Cl]Cl,18 Pt(N-Et-en)Cl2,19 and [Pt(N′-Me-dien)Cl]Cl20 were prepared as described in the 
literature. 
2.2.2 Physical Measurements 
2.2.2.1 NMR Spectroscopy.  1H, 13C, and 195Pt NMR spectra were recorded on either a 
400 MHz or a 500 MHz Bruker NMR spectrometer using DMSO-d6, except for 1H NMR studies 
of adduct formation performed in D2O/DMSO-d6 solutions.  Typical concentrations were 10 mM 
for 1H and 13C NMR and 50 mM for 195Pt NMR measurements.  Peak positions are relative to 
TMS (for 1H and 13C in DMSO-d6) or the residual water signal (for 1H in D2O/DMSO-d6).  All 
NMR data were processed using XWINNMR and Mestre-C software.  1H-1H COSY and ROESY 
as well as 1H-13C HSQC and HMBC NMR spectra were recorded in order to assign the signals of 
the products. 512 × 2048 matrices were collected for the 1H-13C HSQC and HMBC experiments. 
Typically, 256 scans were collected per block, and an exponential apodization function with a 
line broadening of 0.2 Hz was used.  The typical JH-C in HMBC experiments was 8 Hz unless 
otherwise stated. The COSY experiments were performed at 25 °C with 16 scans per t1 
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increment.  The evolution dimension was zero-filled to 2K prior to Fourier transformation. 2D 
ROESY experiments were performed at 25 °C by using mixing times of 300 ms (64 scans per t1 
increment).  For 195Pt NMR spectra a pulse width of 20 μs, corresponding to a 30° tip angle, was 
used with a relaxation delay of 0.4 s. Usually, several acquisitions were recorded using a spectral 
window of 75,000 Hz, with 16K data points. Typically 10,000 scans were averaged for each 
acquisition, and the resulting FID was multiplied by an exponential function (LB = 50 Hz) prior 
to Fourier transformation.  All 195Pt NMR chemical shifts were determined in DMSO-d6 
solutions by using cis-Pt(Me2SO)2Cl2 (-3450 ppm) as an external reference, compared to a 
Na2PtCl6 standard.21 Because the shift effect of the deprotonated sulfonamide of Pt(DNSH-
dien)Cl was not as large as expected from the literature on the shift effect of deprotonated 
peptides,22 we examined a particularly wide spectral region from -1300 to -9400 ppm to ensure 
that the signal reported below was from this complex. 
2.2.2.2 Fluorescence Spectroscopy.  Spectra of Pt(II) complexes and 5′-GMP adducts (5 
μM solution in H2O/DMSO-d6, v/v 5/1, pH = 5.5) were recorded in a 10 mm quartz fluorescence 
cuvette, at room temperature, in triplicate by using a Spex Fluorolog-3 spectrofluorimeter 
equipped with a 450 W xenon lamp and a photomultiplier tube detector; all the spectra were 
blank subtracted. Emission spectra were recorded at the excitation wavelength, 360 nm. 
2.2.3 Synthesis of Pt(II) Complexes 
2.2.3.1 Synthesis of Pt(DNSH-dienH)Cl2 (1). A suspension of cis-Pt(Me2SO)2Cl2 (150 
mg, 0.355 mmol) in methanol (20 mL) was treated with DNSH-dienH (119 mg, 0.355 mmol), 
and the reaction mixture was stirred at room temperature for 24 h. Acetonitrile (60 mL) was 
added slowly to the solution and the yellow solid that precipitated was collected on a filter, 
washed with water and diethyl ether, and dried under vacuum; yield, 87 mg (41%). 1H NMR 
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spectrum (DMSO-d6) (ppm): 8.48 (d, 1H), 8.27 (d, 1H), 8.22 (t, 1H, NH), 8.13 (d, 1H), 7.61 (m, 
2H), 7.25 (d, 1H), 6.98 (s, 1H , NH), 6.15 (s, 2H, NH), 3.42 (s, 2H, CH2), 3.38 (m, 2H, CH2), 
3.15 (m, 4H, CH2), 2.83 (s, 6H, CH3). Anal. Calcd for C16H24Cl2N4O2PtS•1.5H2O•CH3OH: C, 
30.87; H, 4.72; N, 8.47.  Found: C, 31.09; H, 4.57; N, 8.02.  
2.2.3.2 Synthesis of Pt(DNSH-dien)Cl (2). The Pt(DNSH-dien)Cl complex was 
synthesized as above for complex 1, but with triethylamine (40 μL, 0.293 mmol) added to the 
methanol suspension of cis-Pt(Me2SO)2Cl2 immediately after addition of DNSH-dienH. The 
yellow solid that precipitated from the reaction mixture after 24 h of stirring was collected on a 
filter, washed with diethyl ether, and dried under vacuum; yield, 90 mg (45%). 1H NMR 
spectrum (DMSO-d6) (ppm): 8.60 (d, 1H), 8.39 (d, 1H), 8.27 (d, 1H), 7.47 (m, 2H), 7.15 (d, 1H), 
6.61 (s, 1H, NH), 5.29 (s, 1 H, NH), 5.11 (s, 1H, NH), 3.18 (m, 2H, CH2), 2.94 (m, 4H, CH2), 
2.82 (s, 6H, CH3), 2.65 (m, 2H, CH2). Anal. Calcd for C16H23ClN4O2PtS•0.5CH3OH: C, 34.08; 
H, 4.31; N, 9.59. Found: C, 34.47; H, 4.52; N, 9.81.  
2.2.3.3 Synthesis of Pt(DNSH-dien)Br (3).  A suspension of cis-Pt(Me2SO)2Br2 (178 
mg, 0.355 mmol) in methanol (20 mL) was treated with DNSH-dienH (119 mg, 0.355 mmol) 
and triethylamine (40 μL, 0.293 mmol), and the reaction mixture was stirred at room temperature 
for 18 h.  The pale yellow solid that precipitated was collected on a filter, washed with diethyl 
ether, and dried under vacuum; yield, 91 mg (42%). 1H NMR spectrum (DMSO-d6) (ppm): 8.62 
(d, 1H), 8.38 (d, 1H), 8.27 (d, 1H), 7,49 (t, 1H), 7.44 (t, 1H), 7.17 (d, 1H), 6.64 (s, 1H, NH), 5.32 
(s, 1H, NH), 5.14 (s, 1H , NH), 3.29 (d, 2H, CH2), 3.05 (m, 4H, CH2), 2.81 (s, 6H, CH3), 2.65 
(m, 2H, CH2). Anal. Calcd for C16H23BrN4O2PtS•H2O: C, 30.58; H, 4.01; N, 8.92. Found: C, 
30.64; H, 3.81; N, 8.79. 
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2.2.3.4 Synthesis of Pt(DNS-dien) (4). Pt(DNS-dien) was synthesized as described for 
complex 2, but with a 10-fold excess of triethylamine added (500 μL, 3.66 mmol). Yield of 
yellow solid, 136 mg (72%). 1H NMR spectrum (DMSO-d6) (ppm): 8.27 (d, 1H), 7.98 (d, 1H), 
7.36 (t, 1H), 7.22 (d, 1H), 6.81 (d, 1H), 5.72 (s, 1H, NH), 5.53 (s, 1H, NH), 5.42 (s, 1H, NH), 
3.64 (m, 2H, CH2), 3.16 (m, 2H CH2), 2.84 (m, 2H, CH2), 2.71 (s, 6H, CH3), 2.64 (m, 2H, CH2). 
Anal. Calcd for C16H22N4O2PtS•0.5CH3OH: C, 36.41; H, 4.43; N, 10.25. Found: C, 36.41; H, 
4.07; N 10.11. 
2.2.3.5 Synthesis of [Pt(DNSH-tren)Cl]Cl (5). A suspension of cis-Pt(Me2SO)2Cl2 (200 
mg, 0.474 mmol) in methanol (20 mL) was treated with DNSH-tren (180 mg, 0.474 mmol), and 
the reaction mixture was heated at reflux for 1 h. The pale yellow solid that precipitated after 
reducing the volume to 5 mL was collected on a filter, washed with water and diethyl ether, and 
dried in vacuo; yield, 105 mg (35%). 1H NMR spectrum (DMSO-d6) (ppm): 8.48 (d, 1H), 8.24 (t, 
1H, NH), 8.23 (d, 1H), 8.13 (d, 1H), 7.65 (m, 1H), 7.26 (d, 1H), 5.66 (s, 1H, NH), 5.37 (s, 2H, 
NH), 3.46 (t, 2H, CH2), 3.07 (m, 2H, CH2), 2.76 (m, 4H, CH2), 2.82 (s, 6H, CH3). Anal. Calcd 
for C18H29Cl2N5O2PtS•2H2O: C, 31.72; H, 4.88; N, 10.28. Found: C, 31.74; H, 4.74; N, 9.99. 
2.2.4 Formation of Biological Adducts 
Solutions to study formation of adducts (5 mM in Pt) utilized D2O/DMSO-d6 (500 
μL/100 μL) solutions. DMSO-d6 was used to improve solubility; however solutions of both 
Pt(DNSH-dien)Cl and [Pt(DNSH-tren)Cl]Cl with a higher percentage of water were readily 
prepared (e.g. 5 mM in 95% H2O and 0.1 mM in 99.9% H2O). 
2.2.4.1 G/3′-IMP Reactions. Solutions of adducts (5 mM) were prepared by treatment of 
Pt(DNSH-dien)Cl or [Pt(DNSH-tren)Cl]Cl in D2O/DMSO-d6 (500 μL/100 μL) with a 
stoichiometric amount of a guanine (G) or hypoxanthine derivative (3′-IMP) at pH ~ 5 (pH was 
 14
uncorrected). Reactions were monitored by 1H NMR spectroscopy until the disappearance of free 
G/3′-IMP was indicated or until a constant intensity ratio between free and complexed G/3′-IMP 
was attained. When necessary, DNO3 and NaOD solutions (0.01 M in D2O) were used for 
adjusting the pH of each sample directly in the NMR tubes. 1D and 2D NMR studies were 
performed at 25 °C. Methanol-d4 was added to the samples for low-temperature experiments. 
2.2.4.2 Methionine Reactions. We chose conditions, such as pH, and ratios to mimic 
those reported previously for the parent compound, [Pt(dien)Cl]Cl.8 Challenge Reactions. 
Solutions of Pt(DNSH-dien)Cl or [Pt(DNSH-tren)Cl]Cl in D2O/DMSO-d6 (500 μL/100 μL) were 
treated with a stoichiometric amount of methionine at pH ~6.4. Reactions were monitored by 1H 
NMR spectroscopy until the disappearance of free met was indicated or until a constant ratio 
between free and complexed met was attained. Then 1 eq. of 5′-GMP (final ratio of Pt:met:5′-
GMP = 1:1:3) was added. The complementary challenge reaction, addition of 1 eq of met to a 
solution of the Pt(DNSH-dien)(5′-GMP) adduct, was also investigated (final ratio of Pt:met:5′-
GMP = 1:1:3). Competition Reactions. Solutions of Pt(DNSH-dien)Cl and [Pt(DNSH-
tren)Cl]Cl in D2O/DMSO-d6 (500 μL/100 μL) were treated with met and 5′-GMP at pH ~6.4 
(Pt:met:5′-GMP = 1:1:3) and the reactions monitored by 1H NMR spectroscopy. 
2.3 Results 
2.3.1 NMR Characterization of Pt(II) Complexes 
2.3.1.1 Pt(DNSH-dienH)Cl2 (1). Reaction of cis-Pt(Me2SO)2Cl2 with DNSH-dienH with 
no added base affords Pt(DNSH-dienH)Cl2 (1) (Figure 2.2). Immediately upon dissolution of 1 
in DMSO-d6, one major and one minor set of NH signals were observed. The minor set, which 
disappeared after ~5 min but reappeared on addition of [Et4N]Cl (not shown), was assigned to 1, 
and the major set was assigned to the solvolysis product, [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-
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sol), on the basis of its 195Pt NMR chemical shift (-3318 ppm), which was very similar to that of 
[Pt(en)(Me2SO-d6)Cl]+ (-3307 ppm).23 NMR data are summarized in Table 2.1. The 1H NMR 
aromatic signals of [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ in DMSO-d6 (Figure 2.3) compared to 
those of DNSH-dienH are not significantly affected by Pt binding to the DNSH-dienH ligand. 
The 1H NMR NH signals of DNSH-dienH cannot be observed in DMSO-d6 unless DNO3 is 
added. We attribute this result to fast NH exchange. However, once the ligand binds to Pt(II) 
through N1 and N2 (for numbering, refer to Figure 2.1), the NH signals appear. We attribute this 
result to slower NH exchange for the coordinated ligand.  
 
Figure 2.3. Aromatic 1H NMR signals of the Pt(II) complexes formed by DNSH-dienH ligand; 
in DMSO-d6, [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol), [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), 
Pt(DNS-dien) (4). 
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Table 2.1. 1H NMR and 195Pt NMR Shifts (ppm) for Selected Ligands and Complexesa 
  ligandsb Pt(II) complexc 
  DNSH-
dienH 
DNSH
-tren 1 1-sol 2 2-sol 3 4 5 5-sol 6 6-sol 
195Pt NMR 
    -3318 -2499 -3222  -3235 -2634 -3364 -2721 -3465 
1H NMR 
NMe2 2.83 2.82 2.83 2.83 2.82 2.82 2.81 2.71 2.82 2.82   
N1H   5.23 6.15 5.11 5.97 5.14 5.42 5.37 6.31 5.43 6.55 
   5.34  5.29 6.34 5.32 5.53 5.66 5.95 5.51 6.66 
N2H   6.27 6.98 6.61 7.89 6.64 5.72   7.34 8.39 
N3H   8.05 8.22     8.24 8.26   
H2 8.11 8.11 8.13 8.13 8.27 8.25 8.27 7.98 8.13 8.13   
H3 7.59 7.59 7.61 7.61 7.47 7.61 7.44 7.22 7.65 7.65   
H4 8.29 8.30 8.27 8.27 8.39 8.40 8.38 8.27 8.23 8.23   
H6 7.25 7.25 7.25 7.25 7.15 7.24 7.17 6.81 7.26 7.26   
H7 7.61 7.61 7.61 7.61 7.47 7.61 7.49 7.36 7.65 7.65   
H8 8.46 8.45 8.48 8.48 8.60 8.50 8.62  8.48 8.48   
a10 mM, DMSO-d6, 25 °C. bChemical shifts of NH signals of protonated ligands, DNSH-dienH: 7.98 (N1H), 8.74 (N2H), 8.30 
(N3H) and DNSH-tren: 8.01 (N1H), 8.37 (N3H). cPt(DNSH-dienH)Cl2 (1), [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol), Pt(DNSH-
dien)Cl (2), [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), Pt(DNSH-dien)Br (3), Pt(DNS-dien) (4), [Pt(DNSH-tren)Cl]Cl (5), [Pt(DNSH-
tren)(Me2SO-d6)]2+ (5-sol), [Pt(dien)Cl]Cl (6), and [Pt(dien)(Me2SO-d6)]2+ (6-sol). 
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The presence of the sulfonamide N3H signal (broad triplet, JH-H = 5.3 Hz) is an indication 
that N1 and N2 participate in the binding to Pt(II) but N3 does not. For N3 to bind Pt(II), it must 
be deprotonated. Thus, the NH signals of the DNSH-dienH ligand provide very useful 
information for assessing the formation of the Pt(DNSH-dienH)Cl2 complex.  
The combined use of 1H-1H COSY and ROESY NMR experiments allowed assignment 
of all the aromatic signals. In particular, two sets of coupled signals have been identified from 
the COSY spectrum, corresponding to the DNSH H2, H3, and H4 protons and H6, H7, and H8 
protons (for numbering, refer to Figure 2.1). The ROESY cross-peaks between the 
dimethylamino signal and two aromatic signals allowed identification of the H4 and H6 signals 
and, from these, of the other signals. 1H-13C HMBC and HSQC NMR experiments were used for 
13C NMR signal assignment (Table 2.2). From the 1H-13C HSQC NMR experiment, the signals 
of the carbons bearing a proton were identified easily because the proton spectrum was already 
assigned. The HMBC cross-peak between the proton signal of the DNSH dimethylamino group 
with the C5 signal was the key in assigning the rest of the peaks.  
2.3.1.2 [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol). Soon after Pt(DNSH-dien)Cl (2) (Figure 
2.2) was dissolved in DMSO-d6, two sets of 1H NMR signals were observed. After ~2 h one set 
of signals disappeared. This set reappeared when [Et4N]Cl was added (not shown). The two sets 
are thus clearly from the Pt(DNSH-dien)Cl complex (2) and the solvolysis product, [Pt(DNSH-
dien)(Me2SO-d6)]+ (2-sol). The latter predominates and is almost the exclusive species present in 
the absence of added chloride salt. The data presented here are for [Pt(DNSH-dien)(Me2SO-d6)]+ 
(Figure 2.3). 1H and 13C NMR spectral assignments, summarized in Tables 2.1 and 2.2, were 
made in the same way as for [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol). The most significant 
difference in the spectra of 2-sol (with a tridentate ligand) and 1-sol (with a bidentate ligand) is 
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the absence of the sulfonamide N3H signal for 2-sol. For the [Pt(DNSH-dien)(Me2SO-d6)]+ 
cation, the most upfield aromatic 13C NMR signal is C6 (114.9 ppm). An H8-C6 cross-peak is 
present in the HMBC spectra of [Pt(DNSH-dien)(Me2SO-d6)]+ and [Pt(DNSH-dienH)(Me2SO-
d6)Cl]+ (not shown). In aqueous/DMSO-d6 (500 μL/100 μL), 2 immediately gave evidence for a 
solvolysis product; careful studies varying solvent composition indicate this species, which is 
involved in the G/3′-IMP reactions and the 5′-GMP/met competition reactions, is [Pt(DNSH-
dien)(Me2SO-d6)]+ (2-sol). When 2-sol was heated at 70 °C for 14 h in D2O/DMSO-d6 (500 
μL/100 μL) the H8 DNSH signal disappeared and H7 became a doublet; an incipient AB pattern 
between H7 and H6 signals was observed. The fluorescence emission spectrum of 2-sol is less 
intense than that of 1-sol, Figure 2.4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4. Fluorescence emission spectra of the DNSH-dienH and DNSH-tren ligands and their 
Pt(II) complexes. 
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Table 2.2. 13C NMR Chemical Shifts (ppm) for [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol), 
[Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), and Pt(DNS-dien) (4) Complexes in DMSO-d6 (10 mM, 
25 °C) 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.1.3 Pt(DNS-dien) (4). This product (4), formed under the most basic conditions used, 
has 5 of the 6 aromatic 1H NMR signals expected (Figure 2.3), providing evidence that 4 is 
Pt(DNS-dien) (Figure 2.2). Two sets of coupled signals were identified by the COSY spectrum 
(Figure 2.5A), corresponding to the DNS protons, H2, H3, and H4 of one ring, and H6 and H7 of 
the ring containing the dimethylamino group. In the ROESY experiment (Figure 2.5B), cross-
peaks were observed between the H7 signal and the two N1H signals of the dien moiety. Also, 
the expected H6-H7, H2-H3, and H3-H4 cross-peaks were observed. All aromatic signals were 
upfield (Table 2.1) compared to the corresponding signals of [Pt(DNSH-dien)(Me2SO-d6)]+ (2-
sol). Of note, the H7 signal is coupled to 195Pt (JPt-H = 22 Hz).  
 Pt(II) complex
 1-sol 2-sol 4 
NMe2 45.1 45.1 45.3 
C1 135.4 137.2 141.7 
C2 127.9 127.0 121.6 
C3 123.5 123.6 121.8 
C4 129.0 129.1 126.3 
C5 151.2 151.1 145.8 
C6 115.2 114.9 114.0 
C7 128.5 127.3 128.4 
C8 119.0 119.9 126.8 
C9 129.1 129.6 137.0 
C10 129.8 128.3 128.9 
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1H-13C HSQC and HMBC NMR experiments were used to assign the 13C NMR spectrum 
(Table 2.2) and to confirm the structure of 4. For Pt(DNS-dien) three 1H-13C HMBC experiments 
were carried out with different JH-C values (6.25, 8, and 10 Hz), but none of the spectra exhibited 
an H8-C6 cross-peak as found in 1H-13C HMBC experiments (JH-C = 8 Hz) with [Pt(DNSH-
dien)(Me2SO-d6)]+ and [Pt(DNSH-dienH)(Me2SO-d6)Cl]+. 
 
 
Figure 2.5. A 1H-1H COSY spectrum of Pt(DNS-dien) in DMSO-d6 at 298 K.  B. 1H-1H ROESY 
spectrum of Pt(DNS-dien) in DMSO-d6 at 298 K. 
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2.3.1.4 [Pt(DNSH-tren)Cl]Cl (5). [Pt(DNSH-tren)Cl]Cl (5) (Figure 2.2) was prepared by 
treating cis-Pt(Me2SO)2Cl2 with DNSH-tren. In DMSO-d6 the 1H NMR aromatic signals of the 
DNSH group are not significantly affected by Pt binding (Table 2.1). Upon dissolution in 
DMSO-d6 the signals of 5 decreased slightly and a downfield set of NH 1H NMR signals for 
[Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol) increased. However, only ~10% of [Pt(DNSH-
tren)(Me2SO-d6)]2+ (5-sol) formed. In contrast, when 5 was dissolved in a mixture of 
aqueous/DMSO-d6 (500 μL/100 μL, pH = 6.3), 5-sol formed to a much greater extent (~85% 
after 2 hours). 5-sol was the reactive species present in the G/3′-IMP reactions and the 5′-
GMP/met competition reaction. 
2.3.2 Pt(DNSH-dien)(G/3′-IMP) and Pt(DNSH-tren)(G/3′-IMP) Adducts 
The solvent used for all adducts was D2O/DMSO-d6, 500 μL/100 μL, unless otherwise 
specified. For low temperature experiments, the solvent mixture was D2O/DMSO-d6/methanol-d4 
(500 μL/100 μL/100 μL).  
2.3.2.1 Pt(DNSH-tren)(G/3′-IMP) (G = 3′-GMP, 5′-GMP). The Pt(DNSH-tren)(3′-
GMP) adduct (pH = 6.32) exhibited one H8 and one H1′ NMR signal downfield of the respective 
signals of free 3′-GMP (Table 2.3). The aromatic signals of the DNSH group were not shifted by 
3′-GMP binding (Table 2.4). 
Results similar to those for Pt(DNSH-tren)(3′-GMP) were observed for the Pt(DNSH-
tren)(5′-GMP) adduct. For Pt(DNSH-tren)(3′-IMP), the resonances of both H8 and H2 shifted 
downfield of the corresponding resonances of free 3′-IMP. Selected 1H NMR shifts for both free 
and bound G/3′-IMP in Pt(DNSH-tren)(G/3′-IMP) adducts are listed in Table 2.3.  
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Table 2.3. 1H NMR Chemical Shifts (ppm) for Pt(DNSH-dien)(G/3′-IMP) and Pt(DNSH-
tren)(G/3′-IMP) Adducts in D2O/DMSO-d6  500 μL/100 μL, 25 °C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.3.2.2 Pt(DNSH-tren)(met-S)]2+. We studied the spectrum of the [Pt(DNSH-tren)(met-
S)]2+ adduct (pH = 6.4, at which met has a neutral overall charge), which exhibited a sharp 
(FWHM = 3 Hz) S-methyl NMR signal (2.51 ppm) downfield of the S-methyl signal of free met 
G/3′-
IMP pH 
free H8 
(H2) 
H8  
(H2) 
free 
H1' H1' 
Pt(DNSH-tren)(G/3′-IMP) 
5'-GMP 6.32 8.09 8.61 5.89 5.96
3'-GMP 6.32 8.00 8.40 5.90 5.94
3′-IMP 6.26 8.38 8.83 6.12 6.17
  (8.23) (8.30)   
Pt(DNSH-dien)(G/3′-IMP) 
9-EtG 5.23 8.01 8.11   
5'-GMP 5.21 8.11 8.27 5.87 5.69
   8.25   
3'-GMP 5.20 8.04 8.30 5.91 5.81
   8.28   
5'-GDP 5.25 8.14 8.30 5.90 5.69
   8.28   
5'-GTP 5.17 8.15 8.30 5.89 5.68
   8.27   
3'-IMP 5.23 8.39 8.72 6.13 6.01
  (8.22) (8.10)   
   8.69   
   (8.09)   
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(2.13 ppm). The α CH signal of [Pt(DNSH-tren)(met-S)]2+ was downfield (3.90 ppm) of that of 
free met (3.82 ppm). The aromatic and the dimethylamino DNSH signals were not shifted. 
Challenge Reaction. A few hours after addition of three equivalents of 5′-GMP to the solution 
of the [Pt(DNSH-tren)(met-S)]2+ cation, the NMR signals of the bound met decreased, and 
signals of the Pt(DNSH-tren)(5′-GMP) adduct appeared. After 20 and 40 days, respectively, the 
Pt(DNSH-tren)(5′-GMP) to [Pt(DNSH-tren)(met-S)]2+product distribution was 70:30 and 100:0 
(no signals for the met adduct remained).  Competition Reaction. Figure 2.6 describes the time 
course of the competition reaction of 5-sol with met and 5′-GMP (1:1:3). In the initial stages of 
the competition reaction the peaks of free met decreased in size and the peaks of the [Pt(DNSH-
tren)(met-S)]2+ adduct appeared, while only a small amount of the Pt(DNSH-tren)(5′-GMP) 
adduct was observed (Figure 2.6). In later stages the signals of [Pt(DNSH-tren)(met-S)]2+ began 
decreasing and those of Pt(DNSH-tren)(5′-GMP) increased. Finally, after about two months, 
only Pt(DNSH-tren)(5′-GMP) signals could be detected.   
 
Figure 2.6. Time courses of competition reactions of [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol) and 
[Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol) with met and 5′-GMP. 
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2.3.2.3 [Pt(DNSH-dien)(9-EtG)]+. The [Pt(DNSH-dien)(9-EtG)]+ adduct (pH = 5.23), 
prepared as described above, showed one set of 1H NMR signals. Compared to free 9-EtG, the 
H8 signal was downfield (Table 2.3), but the CH3 and CH2 signals of the ethyl group were 
shifted upfield to 1.17 from 1.48 ppm and to 3.92 from 4.11 ppm, respectively. The DNSH 
signals of the adduct were upfield of the signals of [Pt(DNSH-dien)(Me2SO-d6)]+ (Table 2.4). A 
spectrum recorded at -5 °C showed no broadening of the H8 signal. 
2.3.2.4 Pt(DNSH-dien)(3′-GMP). For Pt(DNSH-dien)(3′-GMP) (pH = 5.20), two 
aromatic singlets of similar intensity (Figure 2.7) integrate to a total of one proton. These singlets 
appear downfield of the H8 signal of free 3′-GMP and are assigned to H8 of bound 3′-GMP by 
two NOE cross-peaks to the H1′ signal.24 There was one H1′ signal for the adduct, upfield of the 
H1′ signal of free 3′-GMP (Table 2.3). Also, only one set of DNSH aromatic signals was 
observed, upfield of the corresponding signals of the starting complex (Table 2.4). Spectra were 
also recorded from -5 °C to 65 °C in 5 °C intervals. The spectra recorded below 25 °C exhibited 
two well-resolved 3′-GMP H8 signals, downfield from the H8 doublet for the DNSH group. In 
spectra measured above 25 °C, these signals began to overlap because the DNSH H8 doublet 
shifted downfield.  Also, the H2 doublet and H3 triplet of the DNSH group each shifted 
downfield and in some cases the spectra indicated that these were in fact two very closely spaced 
overlapping signals (of roughly equal size).  
2.3.2.5 Pt(DNSH-dien)(G/3′-IMP) (G = 5′-GMP, 5′-GDP, 5′-GTP). The 1H NMR 
spectra of the other Pt(DNSH-dien)(G) adducts were similar to that of Pt(DNSH-dien)(3′-GMP) 
(Tables 2.3 and 2.4). The Pt(DNSH-dien)(3′-IMP) adduct gave two upfield-shifted H2 signals in 
addition to the two downfield-shifted H8 signals and one upfield H1′signal, as observed for the 
G adducts (Table 2.3). 
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Table 2.4. 1H NMR Chemical Shifts (ppm) of the DNSH Moiety of ([Pt(DNSH-tren)(Me2SO-
d6)]2+ (5-sol), [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), and Pt(DNSH-dien)(G/3′-IMP) in 
D2O/DMSO-d6 (500 μL/100 μL) 
 
 
5-sol 2-sol Pt(DNSH-dien)(G/3′-IMP) DNSH 
signals   9-EtG 3'-GMP 5'-GMP 3'-IMP 
pH 6.37 5.21 5.23 5.20 5.21 5.23 
NMe2 2.92 2.94 2.94 2.93 2.94 2.93 
H2 8.28 8.40 8.10 8.01 8.03 8.00 
H3 7.74 7.78 7.48 7.48 7.48 7.45 
H4 8.57 8.52 8.22 8.19 8.20 8.19 
H6 7.49 7.49 7.43 7.43 7.45 7.54 
H7 7.78 7.78 7.63 7.66 7.65 7.70 
H8 8.32 8.67 8.30 8.27 8.26 8.27 
 
 
2.3.2.6 Pt(DNSH-dien)(met-S). The [Pt(DNSH-dien)(met-S)]+ adduct in D2O/DMSO-d6 
has a broad S-methyl signal (FWHM = 16 Hz, 2.49 ppm), which was downfield of this signal in 
the spectrum of free met (2.18 ppm). Challenge Reaction. No replacement of the bound met or 
bound 5′-GMP was observed even 60 days after addition of three equivalents of 5′-GMP to the 
met adduct or one equivalent of met to the 5′-GMP adduct, respectively. Competition Reaction. 
[Pt(DNSH-dien)(Me2SO-d6)]+ was treated with met and 5′-GMP (1:1:3). Roughly equal amounts 
of [Pt(DNSH-dien)(met-S)]+ and Pt(DNSH-dien)(5′-GMP) were formed throughout the course of 
the reaction (Figure 2.6).  
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Figure 2.7. Aromatic region of the 1H NMR spectrum of the Pt(DNSH-dien)(3′-GMP) adduct. 
 
2.4 Discussion 
2.4.1 Pt(DNSH-dienH)Cl2 (1)  
Under the least basic synthetic conditions used, cis-Pt(Me2SO)2Cl2 and DNSH-dienH 
formed Pt(DNSH-dienH)Cl2, with DNSH-dienH acting as a bidentate ligand (central N2 and 
terminal N1) (Figure 2.2). One key piece of evidence for this conclusion is the presence of the 
sulfonamide N3H 1H NMR signal at a shift similar to that of the free DNSH-dienH ligand, as 
expected for an unbound sulfonamide group because N3H must deprotonate prior to Pt binding. 
Pt(en)Cl2 and Pt(N-Et-en)Cl2 (N-Et-en = N-ethylethylenediamine), when dissolved in DMSO-d6, 
give the monosolvated species, in which only one Cl ligand is replaced by DMSO.23,25 1H NMR 
data indicate that DMSO replaces one of the two chlorides of Pt(N-Et-en)Cl2 more readily than 
the other one. The 195Pt NMR shifts for Pt(en)Cl2 and Pt(N-Et-en)Cl2 are -2345 and -2364 ppm, 
respectively, whereas these are -3307 and -3325 ppm for [Pt(en)(Me2SO-d6)Cl]+ 23 and [Pt(N-Et-
en)(Me2SO-d6)Cl]+, respectively. [Pt(en)(Me2SO-d6)2]2+ has a 195Pt NMR chemical shift of -3650 
ppm.23 The 195Pt NMR shifts of these monosolvated complexes are very close to the value (-3318 
ppm) obtained for [Pt(DNSH-dienH)(Me2SO-d6)Cl]+, thus indicating that in DMSO-d6 only one 
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Cl has been replaced to form [Pt(DNSH-dienH)(Me2SO-d6)Cl]+ (1-sol, Table 2.1). The 
insignificant changes in the shifts of the DNSH 1H NMR signals and in fluorescence intensity 
(see below and Figure 2.4) indicate that the DNSH moiety occupies a remote position relative to 
the Pt. 
2.4.2 Pt(DNSH-dien)X (X = Cl (2) or Br (3)) 
The key spectroscopic evidence that the DNSH-dienH ligand acts as a tridentate ligand in 
Pt(DNSH-dien)X is the absence of the N3H signal indicative of a deprotonated sulfonamide N3, 
a requirement for a sulfonamide to bind to metals. The Cl and Br ligands are readily displaced in 
DMSO-d6 to give [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol). The behavior of Pt(DNSH-dien)X in 
DMSO-d6 is similar to that of [Pt(dien)Cl]Cl.  Immediately after dissolution in DMSO-d6, 
[Pt(dien)Cl]Cl showed two sets of NH NMR signals. The upfield set, assigned to [Pt(dien)Cl]+, 
decreased with time, whereas the downfield set, assigned to [Pt(dien)(Me2SO-d6)]2+, increased 
with time, and a ratio of ~1:1 was observed at equilibrium. The shifts of the central secondary 
NH signals were more downfield than those of the terminal primary amines in both [Pt(dien)Cl]+ 
and [Pt(dien)(Me2SO-d6)]2+.26 The same trends were observed in the spectrum of Pt(DNSH-
dien)Cl in DMSO-d6, in which the NH signals of [Pt(DNSH-dien)(Me2SO-d6)]+ were downfield 
of those of Pt(DNSH-dien)Cl, and the central N2H signal was downfield from the terminal N1H 
signals. Comparing the chemical shifts of the NH signals, we observed that all NH signals were 
shifted upfield for Pt(DNSH-dien)Cl relative to [Pt(dien)Cl]Cl (Table 2.1). The reason for the 
upfield position of the shifts is undoubtedly the stronger electron donation to Pt(II) by a 
sulfonamido group than by a terminal amine group.  
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2.4.3 Pt(DNS-dien) (4) 
The DNSH-dienH ligand can act as a quadridentate N3C ligand (terminal N1, central N2, 
and sulfonamido N3 of the dien moiety and C8 of the DNS moiety), giving the chelate complex, 
Pt(DNS-dien) (4) (Figure 2.2). The key evidence for C8 coordination was the missing H8 1H 
NMR signal. The upfield-shifted positions of the aromatic and dimethylamino signals of the 
DNS moiety of 4, vs. the corresponding signals of [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol), are also 
consistent with the formation of a Pt−C8 bond. For example, the H7 signal moved upfield by 
0.25 ppm. Furthermore, the coupling to 195Pt of the proton (H7) on the carbon adjacent to the 
metallated carbon (C8) was 3JPt-H = 22 Hz. These results are comparable to those observed in 
related Pt(II) complexes.27-29 For example, Carlone et al.29 found that in a Pt(II) complex with 3-
nitro-9-[(2-dialkylaminoethyl)amino]acridine attached by a Pt–C bond the resonance for the 
proton adjacent to the Pt−C bond shifted upfield by 0.26 ppm and was coupled to 195Pt (3JPt-H = 
35 Hz).29 The C8 13C NMR signal of 4 had shifted downfield from the free ligand signal after 
formation of the Pt–C bond, as reported for other Pt(II) complexes with a Pt–C bond. (X-ray 
structural analysis was also used to confirm the formation of the Pt−C bond in several cases).27,30 
The N2H signal of the N3C complex is relatively upfield (by ~1.5 ppm) compared to complexes 
having N,N,N coordination. We believe that this upfield shift is a result of the greater trans 
influence (compared to a Cl or Me2SO-d6 ligand) of the negatively charged C8 atom trans to the 
N2H.  
2.4.4 [Pt(DNSH-tren)Cl]Cl (5) 
This complex was designed to be a control, with the DNSH group remote from Pt. The 
similarity of the DNSH signals to that of the free ligand and the presence of the sulfonamide NH 
signal confirm that the desired structure formed.  An unusual feature of this compound is that it 
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did not readily undergo solvolysis in DMSO-d6 (~10% [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol) 
formed).  The primary amine NH signals of 5 and 5-sol have shifts very similar to those of 
[Pt(dien)Cl]Cl (6) and [Pt(dien)(Me2SO-d6)]2+ (6-sol), respectively. Upon dissolution in DMSO-
d6, 6 converted to an ~1:1 6:6-sol mixture. [Pt(N′-Me-dien)Cl]Cl was used as model for 5 and it 
was found to undergo solvolysis by only ~15%. Thus, the presence of an alkyl group on the 
central N decreases DMSO solvolysis. The shielding effect of Me2SO-d6 compared to Cl causes 
~700 ppm upfield 195Pt NMR shifts of the Me2SO-d6 solvolysis product relative to the starting 
[Pt(dien)Cl]+, [Pt(DNSH-tren)Cl]+, and Pt(DNSH-dien)Cl complexes in DMSO-d6. 
2.4.5 Fluorescence Spectroscopy  
The fluorescence intensity of N-dansyl-N'-ethylthiourea was quenched by 87% after 
addition of Pt(II).31 This significant decrease was attributed to the “heavy atom effect.”31 The 
presence of Pt(II) enhances the rate of the spin-forbidden process (S1 → T1).32-34 The 
fluorescence intensity of the DNSH-tren ligand is decreased by only 20% on formation of 
[Pt(DNSH-tren)(Me2SO)]2+ (Figure 2.4). We attribute the small degree of the decrease to the 
remote position of the fluorophore from the Pt. Fluorescence spectra of [Pt(DNSH-
dienH)(Me2SO)Cl]+, [Pt(DNSH-dien)(Me2SO)]+, and Pt(DNS-dien) showed progressively more 
significant quenching of the fluorescence intensity compared to that of the DNSH-dienH ligand 
(Figure 2.4), probably due to the heavy atom effect33 of Pt(II). The greater quenching of the 
fluorescence intensity as the hapticity of the DNSH-dienH ligand is associated with the increased 
proximity of the dansyl group to the Pt. The high level of quenching of Pt(DNS-dien) relative to 
[Pt(DNSH-dienH)(Me2SO)Cl]+ and [Pt(DNSH-dien)(Me2SO)]+ may also be attributed to the Pt–
C8 bond, which has changed the electronic properties of the fluorophore, in addition to the 
heavy-atom effect.33,34 In the Pt(DNSH-dien)(5′-GMP) adduct, the observed additional 
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quenching is attributed to efficient energy transfer from the naphthalene ring to the guanine 
base.35 The insignificant additional quenching of the fluorescence intensity of Pt(DNSH-tren)(5′-
GMP) relative to that of [Pt(DNSH-tren)(Me2SO)]2+ (5-sol) is explained by the remote position 
of the nucleotide relative to the fluorophore.  
 
 
 
Figure 2.8. The two 6-oxopurine orientations for Pt complexes with dien-type ligands symmetric 
about a plane perpendicular to the coordination plane and bisecting the ligand. For the two 
possible rotamers of Pt(DNSH-tren)(G/3′-IMP) adducts: R is a sugar-phosphate; R′ = H (IMP) or 
NH2 (GMP); R′′ = CH2CH2NHDNSH. For dien analogs, R′′ = H.  
 
2.4.6 Pt(DNSH-tren)(G/3′-IMP) (G = 3′-GMP, 5′-GMP) adducts 
The 6-oxopurine nucleobase of G/3′-IMP lies with its plane roughly perpendicular to the 
Pt coordination plane. In a Pt(II) complex possessing a carrier ligand unsymmetrical with respect 
to the coordination plane but symmetrical about a plane perpendicular to the coordination plane, 
two 6-oxopurine orientations are possible (Figure 2.8), and hence two magnetically inequivalent 
sets of signals are expected for slow rotation of the 6-oxopurine about the Pt–N7 bond. For 
Pt(DNSH-tren)(G/3′-IMP) adducts, O6 can be on either the same or the opposite side of the 
coordination plane as the CH2CH2NHDNSH substituent. In related cases with tridentate dien-
type ligands with both terminal nitrogens substituted, two downfield-shifted H8 signals 
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indicating slow rotation of the two rotamers have been observed.11,12 The observation of only one 
downfield-shifted H8 (and one H2 for 3′-IMP) signal and only one H1′ signal for each 
Pt(DNSH-tren)(G/3′-IMP) adduct is attributed to nucleobase binding to Pt via N7 and to rapid 
rotation around the Pt–N7 bond preventing the observation of separate signals for the two 
rotamers. For Pt(dien)(G) adducts, fast rotation around the Pt–N7 bond is expected because both 
terminal nitrogens are primary amino groups. Only one H8 signal was observed,36 as expected. 
The aromatic signals of the DNSH group were unaffected by G/3′-IMP binding to [Pt(DNSH-
tren)(Me2SO-d6)]2+ (5-sol), most likely because the DNSH group is not close to the bound 6-
oxopurine base.  
2.4.7 [Pt(DNSH-tren)(met-S)]2+ Adduct 
The downfield shifts of the S-methyl and CH signals of met on binding to [Pt(DNSH-
tren)(Me2SO-d6)]2+ (5-sol) reported above are attributed to S binding to Pt. Similar shifts were 
reported for [Pt(dien)(met-S)]2+.8,37 Thus, the adduct is [Pt(DNSH-tren)(met-S)]2+. Challenge 
reaction. After addition of 5′-GMP to a [Pt(DNSH-tren)(met-S)]2+ solution, the met-S adduct 
converted completely to the 5′-GMP adduct. This result was expected because the 5′-GMP 
adduct is expected to be the thermodynamic product on the basis of challenge studies reported 
for the [Pt(dien)(met-S)]2+ adduct.37 Competition reaction. Initially the [Pt(DNSH-tren)(met-
S)]2+ adduct formed to a much greater extent than the Pt(DNSH-tren)(5′-GMP) adduct in a 
competition reaction of met and 5′-GMP for [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol), indicating 
that [Pt(DNSH-tren)(met-S)]2+ was the preferred kinetic product. With time, the N7-bound 5′-
GMP (thermodynamic) product formed (Figure 2.6), as found previously for the [Pt(dien)(met-
S)]2+ and [Pt(dien)(GSMe-S)]2+ adducts.6,8,37 At 40 h at the same pH (6.3) and same Pt(II):met:5′-
GMP ratio (1:1:3), 5-sol formed 55% of the met adduct, while [Pt(dien)(H2O)]2+ formed 42% of 
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the met adduct.8 These results of intermolecular displacement support the previous findings that 
the Pt−S (thioether) bond is the kinetically favored bond type, whereas the Pt−N7 bond is the 
thermodynamically favored bond type.8 Because the dansyl fluorophore of 5-sol is positioned 
away from the Pt(II) binding site, its presence did not affect the reactivity or selectivity toward 
N-bearing (GMP) or S-bearing (met) biological targets of Pt(II).  
2.4.8 Possible Rotamers for the Pt(DNSH-dien)(G/3′-IMP) Adducts  
Although the central N2 is not substituted as in 5, the central N2H atom breaks the 
symmetry of the Pt coordination plane in Pt(DNSH-dien)(G/3′-IMP) adducts. Therefore the 
nucleobase, which is perpendicular to the plane, has two orientations (Figure 2.9). Also, the 
DNSH group has two possible orientations, with the dimethylamino group on the same or the 
opposite side of the coordination plane as the central N2H. Four rotamers are conceivable for the 
Pt(DNSH-dien)(G/3′-IMP) adduct illustrated. However, the DNSH group normally exhibits fast 
rotation around the C-sulfonamide bond,38 leading to averaging of the signals of the different 
rotamers involving the DNSH group. Thus, for slow Pt–N7 rotation, two rotamers at most can be 
detected on the NMR time scale for each of the two Pt(DNSH-dien) chiralities. 
2.4.9 [Pt(DNSH-dien)(9-EtG)]+ 
[Pt(DNSH-dien)(9-EtG)]+ has only one 9-EtG H8 signal, which showed no broadening 
even in a spectrum recorded at -5 °C, indicating that rotation around the Pt–N7 bond is too fast to 
allow observation of separate signals for the two rotamers.39 Usually, when 9-EtG binds to Pt(II), 
the Et group signals move downfield;40 the upfield-shifted Et signals of [Pt(DNSH-dien)(9-
EtG)]+ are undoubtedly due to the proximity of the 9-EtG to the anisotropic DNSH moiety. 
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Figure 2.9. Two of the conceivable rotamers of Pt(DNSH-dien)(G/3′-IMP) complexes. 
Rotamers illustrated have one of the conceivable DNSH orientations and two base orientations 
with O6 on the same and the opposite side of the proton on the central N2.  For 9-EtG (R = ethyl; 
R′ = NH2), the mirror image of the adduct is an enantiomer. For nucleotides (R is a sugar-
phosphate and R′ = H (IMP) or NH2 (GMP)) the adducts with the mirror image of the Pt(DNSH-
dien) moiety are diastereoisomers of the rotamers shown. 
 
Only one H8 signal was observed for the [Pt(DNSH-dien)(9-EtG)]+ adduct.  For G 
adducts, the presence of the sugar-phosphate group is known to slow rotation.12,39 Because the 
rotation around the Pt–N7 bond in [Pt(DNSH-dien)(9-EtG)]+ could be faster than in nucleotide 
adducts, we investigated Pt(DNSH-dien)(nucleotide) adducts to determine if the presence of the 
bulky DNSH moiety on one side of Pt(II) binding site could slow the rotation enough to allow 
the observation of H8 signals of more than one rotamer. 
2.4.10 Pt(DNSH-dien)(G/3′-IMP) (G = 5′-GMP, 5′-GDP, 5′-GTP) 
The results for these Pt(DNSH-dien) 6-oxopurine nucleotide adducts were similar, and 
we shall refer mainly to the results obtained for the 3′-GMP adduct. Two H8 signals of 
approximately equal intensity were observed at 25 °C, as expected if the adducts for each 
Pt(DNSH-dien) chirality are formed to a comparable extent and if for each Pt(DNSH-dien) 
chirality the two 6-oxopurine rotamers rotate rapidly on the NMR time scale about the Pt−N7 
bond. A previous study of the Pt(N-Me3dien)(G) (G = 3′-GMP, 5′-GMP) adducts showed broad 
peaks at room temperature, and low temperature was necessary for the rotation to be slow 
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enough to give sharp NMR signals for the two rotamers.12 Apparently the presence of the bulkier 
DNSH moiety on one side of Pt(II) binding site cannot slow the rotation enough to allow the 
observation of more than one rotamer (for a 6-oxopurine nucleotide) at room temperature.  
The aromatic DNSH and H1′ signals of the Pt(DNSH-dien)(3′-GMP) adduct shifted 
upfield when compared to those of the starting [Pt(DNSH-dien)(Me2SO-d6)]+ complex and free 
3′-GMP, respectively (Tables 2.3 and 2.4). These upfield shifts of the aromatic signals of the 
DNSH group and of the H1′ signal upon adduct formation are consistent with the proximity of 
the 3′-GMP to the DNSH group. On binding of the 6-oxopurine derivatives to Pt, the 3′-IMP H2 
signals are shifted upfield (in contrast to the typical slight downfield shift), and the purine H8 
signals are shifted downfield by about 0.3 ppm (an amount that is less than that for Pt(DNSH-
tren)(G/3′-IMP) (Table 2.3) and less than the typical 0.5 to 0.7 ppm).36,37  
 
 
Figure 2.10. Proposed stacking interaction between the G/3′-IMP base and the DNSH moiety 
viewed along (left) and from the top (right) of the coordination plane.  The average separation of 
the dansyl and the guanine planes is 3.6 Å. 
 
The DNSH aromatic group is attached to the Pt(II) through a sulfonamido group, which 
keeps the naphthalene ring in proximity to the nucleobase. The observation of the relatively 
upfield shifts does not necessarily establish a stacking interaction (Figure 2.10). However, there 
is evidence for purine-aromatic group stacking in Pt(DNSH-dien)(G) adducts. As the 
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temperature was increased from below room temperature to 65 °C, the DNSH moiety signals 
shifted downfield. This result is expected if the upfield shifting at low temperature is in part due 
to stacking, because the average proximity of the two groups, which is fixed by the Pt−N bonds, 
would not change with temperature in the absence of stacking at low temperature. When 
Heetebrij et al.41 treated [Pt(en)(NH2(CH2)6NH-dinitrophenyl)Cl]Cl (a monofunctional complex) 
with 5′-GMP, they observed that the dinitrophenyl group signals shifted upfield, which they 
attributed to a stacking interaction between the guanine base of 5′-GMP and the dinitrophenyl 
group. Stacking is possible because of the long, flexible (CH2)6 chain. Also, the 5′-GMP adduct 
exhibited only one downfield 5′-GMP H8 signal, indicating rapid rotation about the Pt–N7 bond. 
In this regard, this adduct is similar to the G adducts formed by [Pt(dien)Cl]Cl6,36,37 and by 
Pt(DNSH-dien)Cl. The 5′-GMP H8 signal of the Pt(en)(NH2(CH2)6NH-dinitrophenyl)(5′-GMP) 
adduct had a typical downfield shift. The aromatic group is attached by a flexible (CH2)6 chain 
and apparently may not approach the purine base as closely as the dansyl group does in the 
adducts reported here.   
2.4.11 [Pt(DNSH-dien)(met-S)]+ 
The downfield shifts of the S-methyl signal of the [Pt(DNSH-dien)(met-S)]+ adduct are 
attributed to binding of Pt(II) to the S of met.37 When met binds both through S and N, the rate of 
inversion at S decreased enough that broadening can be observed in NMR spectra.42 A slightly 
later report concluded that, in the [Pt(dien)(met-S)]2+ adduct, where met is bound only through S, 
the inversion is fast on the NMR scale and therefore broadening of the S-methyl signal was not 
observed.37 Our finding that the S-methyl signal for the [Pt(DNSH-tren)(met-S)]2+ adduct is 
sharp appears to support this suggestion. However, if the S of the monodentate met of the 
[Pt(DNSH-dien)(met-S)]+ adduct inverted rapidly, we should observe two sharp S-methyl 
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signals, one for each Pt(DNSH-dien) chirality. If these signals overlapped, the overlapped signal 
should be sharp.  The broad S-methyl signal of the [Pt(DNSH-dien)(met-S)]+ adduct suggests a 
possible alternative explanation for the sharp S-methyl signal of [Pt(dien)(met-S)]2+: the 
difference in shifts for the two [Pt(dien)(met-S)]2+ diastereoisomers is too small to cause 
broadening of the S-methyl signal.  If this explanation holds, then the rate of inversion at S 
cannot be assessed by 1H NMR methods when the two cis coordination environments are too 
similar.  Challenge Reactions. No replacement of the bound monodentate ligand was observed 
after addition of 5′-GMP or met to a solution of the [Pt(DNSH-dien)(met-S)]+ or the Pt(DNSH-
dien)(5′-GMP) adduct, respectively.  The presence of the Pt−sulfonamido bulky group close to 
the binding site affected its selectivity toward N7 over sulfur binding. Competition Reaction. 
No kinetic selectivity of [Pt(DNSH-dien)(Me2SO-d6)]+ (2-sol) toward met over 5′-GMP was 
observed, and the ratio of the two adducts throughout the formation reaction was approximately 
1:1 (Figure 2.6). In contrast, the competition reactions of [Pt(DNSH-tren)(Me2SO-d6)]2+ (5-sol) 
(Figure 2.6) and [Pt(dien)Cl]Cl6,9,10 show preferential kinetic binding by met followed by 
thermodynamic binding by 5′-GMP. The presence of a bulky group very close to the Pt(II) 
binding site in 2-sol significantly affected the selectivity of Pt(II) toward met and 5′-GMP.  
2.5 Conclusions 
The DNSH-dienH ligand can act as a bidentate, tridentate, or quadridentate ligand. The 
observation of only two H8 1H NMR signals for the Pt(DNSH-dien)(6-oxopurine nucleotide) 
adducts indicates rapid rotation around the Pt−N7 bond. Thus, the addition of a bulky substituent 
on just one terminal N of a dien-type ligand has been shown to be insufficient to slow the 
rotation around the Pt−N7 bond. The upfield shifts of the signals of the DNSH group of all G/3′-
IMP adducts, the ethyl group of the 9-EtG adduct, and the H2 and H1′ of nucleotide adducts all 
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indicate that the dansyl naphthalene group and the 6-oxopurine base are close and parallel. The 
additional quenching found for the Pt(DNSH-dien)(5′-GMP) adduct can be attributed to energy 
transfer, which is effective because of the close proximity of the dansyl group to the guanine 
base.35 This quenching is avoided when the aromatic fluorophore is positioned remotely from 
Pt(II), as exemplified by [Pt(DNSH-tren)Cl]Cl. This latter compound and [Pt(dien)Cl]Cl, which 
have no substituents on the terminal amino groups to influence the approach of the incoming 
monodentate ligand, have similar reactivity patterns toward 5′-GMP and met. The resulting 
adducts and those derived from Pt(DNSH-dien)Cl exhibit similar dynamic properties. However, 
the bulky dansyl group near the reaction site of Pt(DNSH-dien)Cl increases the reactivity toward 
5′-GMP relative to that toward met. This effect could be explained by stacking between the 
dansyl group and the guanine base of 5′-GMP. 
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CHAPTER 3. fac-Re(CO)3L COMPLEXES CONTAINING TRIDENTATE 
MONOANIONIC LIGANDS (L¯) WITH A SELDOM-STUDIED SULFONAMIDO 
GROUP AS ONE TERMINAL LIGATING GROUP* 
3.1 Introduction 
Metal nuclide radiopharmaceuticals contain a metal core and an inner ligating unit, 
usually having chelate rings.  We refer to this part of the agent as a label, and important 
properties of the label, which influence biological behavior, are charge and overall shape. 
Technetium-99m (99mTc) is the most widely used diagnostic radionuclide in nuclear medicine.1-4 
{99mTc(V)O}3+ has been the metal core used most predominantly, but recently the development 
of the advantageous [99mTc(CO)3(H2O)3]+ precursor has opened new directions for 
radiolabeling.5-7 Schibli et al. showed that agents with the fac-99mTc(I)(CO)3+ core bearing a 
tridentate coordinated ligand are more robust and have better pharmacokinetic profiles than 
agents bearing bidentate ligands.8 Commonly employed chelating ligands (e.g., 
diethylenetriamine (dien),9 cysteine- and homocysteine-based ligands10,11) contain N, O, or S 
donor atoms in groups such as carboxyls,12 amines,13-19 nitrogen heterocycles,14-16 and 
thioethers.10,11,16,17 
An important approach in the development of small (~5 kDa) metal nuclide 
radiopharmaceuticals is the bioconjugation of a net neutral label to hormones, small peptides, 
etc.20 For fac-99mTc(I)(CO)3+ agents, the ligand(s) occupying the three remaining coordination 
sites must have one negative group close to the metal for net neutrality. A coordinated 
                                                 
* Reproduced with permission from American Chemical Society: Christoforou, A. M., Fronczek, 
F. R., Marzilli, P. A., Marzilli, L. G., "fac-Re(CO)3L Complexes Containing Tridentate 
Monoanionic Ligands (L¯) with a Seldom-Studied Sulfonamido Group As One Terminal 
Ligating Group" Inorganic Chemistry, 2007, in press. Unpublished work copyright 2007 
American Chemical Society. 
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carboxylate group provides such a unit, but it does not provide a point for ligand elaboration or 
for bioconjugation. Consequently, there is a need to evaluate other groups within tridentate 
monoanionic ligands. In this study, we explore ligands which provide one metal-bound negative 
group and which offer a diverse chemistry, allowing bioconjugation via internal ligand atoms or 
via a seldom-used negative terminal ligating group.21 We use ligands containing the sulfonamide 
group, which has been shown to bind well to several metals 22-29 but Tc complexes with this 
group have not been studied.  
The non-radioactive fac-[Re(CO)3(H2O)3]+ analogue is useful in understanding the 
chemistry of agents derived from the [99mTc(CO)3(H2O)3]+ species.10 As a prelude to 
radiopharmaceutical studies, we analyzed a series of new Re(CO)3L complexes formed by 
treating [fac-Re(CO)3(H2O)3]+ with four new ligands, LH, bearing a sulfonamide group (Figure 
3.1). These ligands, tmbSO2-N,N-Me2dienH, tmbSO2-N′-MedienH, tmbSO2-dienH, and tmbSO2-
dipnH, bind in a tridentate fashion involving one nitrogen of a monoanionic deprotonated 
sulfonamido group. The H’s in the ligand names (cf. caption of Figure 3.1) designate the 
sulfonamide NH proton that is absent in the deprotonated bound ligand. We provide the first 
detailed analysis of X-ray structures with a sulfonamido group bound to Re.  
Given the promise of the 99mTc(CO)3L agents (L¯ = a facially coordinated tridentate 
ligand), it is clearly important to understand how the ligand pucker depends on the various 
components that can influence it (donor atoms, chains linking these atoms, exocyclic 
substituents, etc.). Because the chelate ring atoms act as a fulcrum, the configuration of 
asymmetric centers, the shape, and the conformation of the rings can have a large effect on the 
overall shape of the agent, and hence on its biological activity. 
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Figure 3.1. Ligands used in this study: N-[2-(2-dimethylaminoethylamino)-ethyl]-2,4,6-
trimethylbenzenesulfonamide (tmbSO2-N,N-Me2dienH); N-{2-[(2-aminoethyl)-methylamino]-
ethyl}-2,4,6-trimethylbenzenesulfonamide (tmbSO2-N′-MedienH); N-[2-(2-aminoethylamino)-
ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dienH); and N-[3-(3-aminopropylamino)-
propyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dipnH). 
 
Although chelate ring pucker and factors affecting pucker have not been thoroughly 
examined for radiopharmaceuticals, extensive structural information exists for a large number of 
complexes with other metals containing chelate rings with an ethylene group bridge between 
ligating atoms. Many of these structures have been analyzed by using principal component 
analysis (pca) and other methods.30-37 When diethylenetriamine-type ligands bind to a metal 
center in a tridentate fashion, the pucker of the two five-membered chelate rings can have either 
δ or λ chirality (Chart 1), leading to four possible combinations of chelate ring chirality: δλ, λδ, 
λλ, and δδ.  
Chart 3.1 
 
In pca studies on X-ray structures from the Cambridge Structural Database (CSD) of 
[M(dien)2]n+ (M = Ni, Co, Zn, Cu, Cr, Rh, and Ir)31 and of [M(dien)Ln]32 complexes and M(dien) 
 43
fragments30, the δλ and λδ conformation combinations were found much more frequently than 
combinations with the same pucker chirality (δδ and λλ).  On the other hand, Schmidtke and 
Garthoff33 suggested that, because of steric effects of the hydrogen atoms of the ethylene chains, 
fac coordination would favor a δδ or λλ combination.  Thus, factors influencing pucker (which 
in turn affect shape) are not well understood, and in a recent study, we found that the rings have 
the same pucker in complexes of lanthionine (LANH2).11 The new Re(CO)3L complexes studied 
here offer the opportunity to determine how widespread the occurrence of δλ and λλ 
combinations is.  
3.2 Experimental Section 
3.2.1 Starting Materials 
N,N-dimethyldiethylenetriamine (N,N-Me2dien) from Ames Laboratories, N-methyl-2,2′-
diaminodiethylamine (N′-Medien) from TCI America, and bis(3-aminopropyl)amine (dipn), 
dien, 2-mesitylenesulfonyl chloride (tmbSO2Cl), dansyl chloride (DNS-Cl), and Re2(CO)10 from 
Aldrich were all used as received. The DNS-dienH ligand (N-(2-((2-aminoethyl)amino)ethyl)-5-
(dimethylamino)naphthalene-1-sulfonamide)38 and the [Re(CO)3(H2O)3]OTf10 (OTf = 
trifluoromethanesulfonate) precursor were prepared by known methods. 
3.2.2 Physical Measurements 
1H NMR spectra were recorded on either a 300 MHz or 400 MHz spectrometer.  Peak 
positions are relative to TMS or solvent residual peak, with TMS as reference.  All NMR data 
were processed with XWINNMR and Mestre-C software. IR spectra were recorded on a Bruker 
TENSOR 37 spectrometer, and the values for the CO stretching frequencies are given in 
Appendix B.39 
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3.2.2.1 X-ray Data Collection and Structure Determination. All single crystals 
suitable for X-ray crystallography were obtained by slow evaporation from acetone or methanol. 
Single crystals were placed in a cooled nitrogen gas stream at ~100 K on a Nonius Kappa CCD 
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα 
(0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan method, 
with HKL SCALEPACK.40 All X-ray structures were determined by direct methods and 
difference Fourier techniques and refined by full-matrix least squares techniques, by using 
SHELXL97.41 All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were 
visible in difference maps, but were placed in idealized positions. One methyl group (C17) of 5 
has its hydrogen atoms disordered into a "doughnut" of electron density, which was modeled as 
six half-populated positions. A torsional parameter was refined for each methyl group. Mercury 
Software was used as aid for measuring structural parameters. 
3.2.3 Synthesis of Re(CO)3L  
The crude ligands, LH, were synthesized by a slight modification of Krapcho’s method.42 
A solution of the sulfonyl (tmbSO2Cl) or acetyl chloride (tmbCOCl) (~5 mmol, 100 mL of 
dioxane) was added dropwise over the course of about 2 h to a solution of the amine (~50 mmol, 
100 mL of dioxane). The reaction mixture was stirred at RT for 10 h. The dioxane was 
completely removed under vacuum, and water (50 mL) was added. The product was extracted 
into CH2Cl2 (2 × 100 mL), and the solvent was removed under rotary evaporation. The oil thus 
obtained was used to synthesize the Re(CO)3L complexes as follows: an aqueous solution of 
[Re(CO)3(H2O)3]+ (10 mL, 0.1 mmol) was treated with a methanol (1 mL) solution of the ligand 
(0.1 mmol). The pH was adjusted to ~5 and the reaction mixture was heated at reflux for 10 h, 
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then allowed to cool at RT, and the pH was increased to ~ 7. The resulting white solid that 
precipitated was collected on a filter, washed with water, and dried under vacuum.  
3.2.3.1 Re(CO)3(tmbSO2-N,N-Me2dien) (1). This general method just described, with 
tmbSO2Cl (1 g) and N,N-Me2dien (6.5 mL), yielded the crude tmbSO2-N,N-Me2dienH ligand 
(750 mg, 51% yield). 1H NMR (ppm) in CDCl3: 6.94 (s, 2H), 2.90 (t, 2H, CH2), 2.66 (t, 2H, 
CH2), 2.64 (s, 6H, CH3), 2.55 (t, 2H, CH2), 2.33 (t, 2H, CH2), 2.29 (s, 3H, CH3), 2.20 (s, 6H, 
NCH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with tmbSO2-N,N-Me2dienH (32 mg) as 
described above afforded Re(CO)3(tmbSO2-N,N-Me2dien) as a white powder (26 mg, 44% 
yield). Crystals obtained by slow evaporation from methanol were characterized by single-crystal 
X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6: 6.91 (s, 2H), 6.17 (b, 1H, N2H), 
3.54-3.10 (m, 6H, CH2), 3.10 (s, 6H, N-CH3), 2.70 (s, 6H, CH3), 2.59 (m, 2H, CH2), 2.24 (s, 3H, 
CH3). 
3.2.3.2 Re(CO)3(tmbSO2-N′-Medien) (2). The general method, with 1 g of tmbSO2Cl 
and 6 mL of N′-Medien, afforded the crude tmbSO2-N′-MedienH ligand (650 mg, 48% yield). 1H 
NMR (ppm) in CDCl3: 6.95 (s, 2H), 2.93 (t, 2H, CH2), 2.75 (t, 2H, CH2), 2.64 (s, 6H, CH3), 2.44 
(t, 2H, CH2), 2.38 (t, 2H, CH2), 2.29 (s, 3H, CH3), 2.08 (s, 3H, N′-CH3). Treatment of 
[Re(CO)3(H2O)3]+ (0.1 mmol) with tmbSO2-N′-MedienH (30 mg) as described above afforded 
Re(CO)3(tmbSO2-N′-Medien) as a white powder (24 mg, 42% yield). Crystals obtained by slow 
evaporation from acetone were characterized by single-crystal X-ray crystallography. 1H NMR 
(ppm) spectrum in acetone-d6: 6.91 (s, 2H), 4.94 (b, 1H, N1H), 3.87 (b, 1H, N1H), 3.42-3.53 (m, 
3H, CH2), 3.24 (s, 3H, N′-CH3), 3.01-3.18 (m, 5H, CH2), 2.64 (s, 6H, CH3), 2.24 (s, 3H, CH3). 
3.2.3.3 Re(CO)3(tmbSO2-dien) (3). The general method, with tmbSO2Cl (1 g) and dien 
(5.2 mL), yielded the crude tmbSO2-dienH ligand (600 mg, 54% yield). 1H NMR (ppm) in 
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CDCl3: 6.93 (s, 2H), 2.92 (t, 2H, CH2), 2.73 (t, 2H, CH2), 2.67 (t, 2H, CH2), 2.63 (s, 6H, CH3), 
2.59 (t, 2H, CH2), 2.28 (s, 3H, CH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with tmbSO2-
dienH (31.2 mg) as described above afforded Re(CO)3(tmbSO2-dien) as a white powder (21 mg, 
38% yield). Crystals obtained by slow evaporation from methanol were characterized by single-
crystal X-ray crystallography.  1H NMR (ppm) spectrum in acetone-d6: 6.90 (s, 2H), 6.17 (b, 1H, 
N2H), 4.75 (b, 1H, N1H), 3.98 (b, 1H, N1H), 3.36-3.00 (m, 8H, CH2), 2.65 (s, 6H, CH3), 2.24 (s, 
3H, CH3). 
3.2.3.4 Re(CO)3(tmbSO2-dipn) (5). The general method, with tmbSO2Cl (1 g) and dipn 
(6 mL), produced the crude tmbSO2-dipnH ligand (600 mg, 42% yield). 1H NMR (ppm) in 
CDCl3: 6.94 (s, 2H), 2.98 (t, 2H, CH2), 2.76 (t, 2H, CH2), 2.71 (t, 2H, CH2), 2.63 (t, 2H, CH2), 
2.63 (s, 6H, CH3), 2.29 (s, 3H, CH3), 1.62 (m, 4H, CH2). Treatment of [Re(CO)3(H2O)3]+ (0.1 
mmol) with tmbSO2-dipnH (32 mg) as described above afforded Re(CO)3(tmbSO2-dipn) as a 
white powder (24 mg, 41% yield). Crystals obtained by slow evaporation from acetone were 
characterized by single-crystal X-ray crystallography.  1H NMR (ppm) spectrum in acetone-d6: 
6.93 (s, 2H), 5.20 (b, 1H, N2H), 4.64 (b, 1H, N1H), 3.98 (b, 1H, N1H), 3.46 (m, 2H, CH2), 3.28 
(s, 2H, CH2), 3.10-3.19 (m, 3H, CH2), 3.94 (s, 2H, CH2), 2.66 (s, 6H, CH3), 2.25 (s, 3H, CH3), 
1.90 (s, 2H, CH2), 1.66-1.75 (s, 2H, CH2). 
3.3 Results and Discussion 
In a modification of the method of Krapcho,42 monoaddition of the relatively large 
hydrophobic aromatic tmbSO2 group to triamines produced hydrophobic ligands that were 
readily extracted into CH2Cl2 from water (with the excess of unchanged triamine remaining in 
the water layer). This method afforded a series of triamine ligand derivatives (LH) in sufficient 
yield and purity for use in preparing Re complexes. These ligand derivatives bind to the fac-
 47
Re(I)(CO)3 center as tridentate deprotonated monoanionic ligands L¯, thereby forming 
complexes with a neutral core.  
3.3.1 X-Ray Characterization 
Crystal data and structural refinement details are summarized in Table 3.1 for new 
complexes and in Appendix B39 for the previously briefly described compound Re(CO)3(DNS-
dien), 4.43 All the complexes reported here have a distorted octahedral structure, with the three 
carbonyl ligands coordinated facially (Figure 3.2). The remaining coordination sites are occupied 
by two sp3 N amines and one sp2 N from a sulfonamido group.  
 
 
Figure 3.2. Perspective drawings of the S configuration of Re(CO)3(tmbSO2-N,N-Me2dien) (1), 
Re(CO)3(tmbSO2-N′-Medien) (2), Re(CO)3(tmbSO2-dien) (3), and Re(CO)3(tmbSO2-dipn) (5). 
Thermal ellipsoids are drawn with 50% probability. 
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Table 3.1. Crystal Data and Structural Refinement for Re(CO)3L Complexes in Which L¯ 
Contains a Sulfonamido Group 
 
 Re(CO)3L complex 
 1 2 3 5 
empirical 
formula 
C18H26N3O5ReS C17H24N3O5ReS 
•0.5H2O 
C16H22N3O5ReS 
•0.5CH3OH 
C18H26N3O5ReS 
fw 582.68 577.66 570.65 582.68 
crystal 
system 
monoclinic monoclinic triclinic triclinic 
space group C2/c P2/c 1P  1P  
unit cell dimensions 
a (Å) 38.994 (2) 15.945 (2) 7.6603 (5) 7.956 (3) 
b (Å) 14.7085 (10) 10.9504 (15) 7.8808 (5) 11.833 (4) 
c (Å) 14.6254 (10) 12.2394 (16) 16.6154 (12) 12.129 (4) 
α (°) 90.0 90.0 98.181 (4) 115.71(2) 
β (°) 94.642 (4) 100.451 (7) 95.974 (4) 94.66 (2) 
γ (°) 90.0 90.0 98.736 (4) 98.50 (2) 
V (Å3) 8360.8 (9) 2101.6 (5) 973.20 (11) 1003.9 (6) 
T (K) 90 115 90 115 
Z 16 4 2 2 
ρcalc (g/cm3) 1.852 1.826 1.947 1.928 
abs coeff (mm-1) 5.947 5.916 6.386 6.191 
2θmax (°) 71.2 68.4 82.2 52 
R indicesa 0.028 0.039 0.025 0.045 
wR2 = [I> 
2σ(I)]b 
0.063 0.095 0.069 0.091 
data/param 19029/516 7997/253 12822/257 3910/255 
aR = (∑||Fο| - |Fc||)/∑|Fο|; bwR2 = [∑[w(Fο2 - Fc2)2]/∑[w(Fο2)2]]1/2 
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Table 3.2. Selected Bonded and Non-bonded Distances (Å) and Bond Angles (deg) for 
Re(CO)3(tmbSO2-N,N-Me2dien) (1), Re(CO)3(tmbSO2-N′-Medien) (2), Re(CO)3(tmbSO2-dien) 
(3), Re(CO)3(DNS-dien) (4), and Re(CO)3(tmbSO2-dipn) (5) 
 
Re(CO)3L complex 
 1            2                    3                     4      5 
bond distances 
Re–N1 2.2873 (19)/2.2880 (19) 2.222 (4) 2.2247 (15) 2.204 (3) 2.209 (7)
Re–N2 2.2065 (19)/2.2156 (18) 2.232 (3) 2.2172 (15) 2.222 (3) 2.249 (7)
Re–N3 2.2022 (18)/2.2007 (17) 2.195 (3) 2.1898 (15) 2.166 (3) 2.197 (6)
bond angles 
N1–Re–N2 78.87 (7)/78.15 (7) 78.79 (13) 78.24 (6) 77.48 (11) 86.4 (2)
N2–Re–N3 75.89 (7)/75.45 (7) 76.62 (12) 75.96 (5) 74.42 (12) 81.5 (2)
N1–Re–N3 86.79 (7)/86.75 (7) 84.06 (14) 84.06 (6) 82.77 (12) 84.7 (2)
N2–Re–C2 171.57 (9)/172.02 (8) 173.97 (18) 171.58 (7) 171.86 (13) 178.8 (3)
non-bonded distances 
N1 to N2 2.855/2.839 2.826 2.803 2.769 3.051
N2 to N3 2.711/2.702 2.702 2.745 2.653 2.903
C4 to C7 3.258/3.234 3.169 3.206 3.907 
C4H to C7H 2.156/2.112 1.991 2.027 3.927 
C5 to C6 2.496/2.497 2.494 2.509 2.494 
C5H to C6H 2.256/2.269 2.289 2.291 2.361 
 
Typically, the Re−C(3) bond distances, involving the CO group trans to the sulfonamido 
group, are not significantly different from those of the other Re−CO bonds. Although we found 
that the aromatic rings facilitated our efforts to obtain crystals, these rings generally were not 
stacked.  The closest distance between carbons of two benzene rings (3.69 Å) was found for 
Re(CO)3(tmbSO2-N,N-Me2dien) (1), in which the two carbons were in the two slightly different 
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molecules of the asymmetric unit. This distance of 3.69 Å is too long to indicate stacking 
interactions between the aromatic rings. 
3.3.1.1 Bond Lengths and Hybridization. The average Re−N bond length of ~2.2 Å 
(see Table 3.2 for selected bond lengths and angles of the sulfonamido complexes) found in the 
sulfonamido complexes is consistent with distances found in relevant Re(CO)3 complexes 
containing dien, such as [Re(CO)3(dien)]Br.9 The ~0.2 Å longer Re−N bonds in Re(CO)3L 
compared to relevant Pt−N bonds (e.g., including terminal amines (2.063(9) and 2.063(10) Å, 
and the secondary amine, 2.002(8) Å, of [Pt(dien)Cl]Cl44) are explained by the greater radius for 
Re(I). The Re−N1 bond (to the terminal amine) in Re(CO)3(tmbSO2-N,N-Me2dien) (1) is 
significantly longer than the other Re−N bonds in 1 and the other sulfonamido compounds 2-5. 
This lengthening is attributed to the bulkiness of the two methyl groups on N1 (for 1) compared 
to the smaller H group in all other sulfonamido compounds. 
The sp2 N donors can form shorter Re−N bonds than can the sp3 N donors.14,45 Typical 
Re−sp2 N bond lengths range from 2.14 to 2.18 Å, as measured in a number of Re structures 
containing Re−N bonds (aromatic sp2 N, e.g., in pyridyl ligands), whereas a typical Re−sp3 N 
bond length is ~2.2 Å.10,11,14 The sp2-hybridized N3 should affect the S−N3−C7, S−N3−Re, and 
C7−N3−Re angles. However, although we have several structures to compare, the differences 
between molecules were generally consistent with expectations for Re−sp2 N vs. Re−sp3 N 
centers, but are small and thus are masked by steric and solid-state effects. 
The N−SO2 bond lengths for the deprotonated sulfonamido group, between 1.561(3)-
1.5902(18) Å for complexes 1 to 5, are within the relatively broad range for N−SO2 bonds (1.5-
1.7 Å) found in deprotonated sulfonamides bound to a metal (e.g., Cu, Zn, and Ni).22,24 
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Figure 3.3. Absolute configuration. When the structure is viewed with the non-chelate ring 
substituent on N2 projecting away from the viewer (left), the absolute configuration at N2 (left) 
and Re (right) is designated to be S for a counterclockwise trace for the other N substituents (Re, 
R1, and R2) according to higher priority as shown. When the trace is clockwise the absolute 
configuration is R. 
 
3.3.1.2 Bite Angles. The N1 to N2 and N2 to N3 distances within five-membered chelate 
rings in the Re(CO)3L complexes have a narrow range of values (Table 3.2). The distances of 
about 2.7 Å are similar to relevant distances in complexes with higher valent metal centers (e.g., 
Re(V) and Pt(II)) with shorter M−N bonds (~2 Å) (e.g., in [Pt(dien)Cl]Cl the N to N distances 
average about 2.72 Å).44 The combination of the long Re−N bonds (compared to other M−N 
bonds) and typical N to N distances results in more acute values for N−Re−N chelate ring bite 
angles (less than 90°) and for trans N−Re−C angles (less than 180°) (see Table 3.2). For 
complexes with five-membered rings (1-4), the N2−Re−N3 bite angle (N3 is part of the 
sulfonamido group) is smaller (74.42°-76.62°) than the N1−Re−N2 bite angle (77.5°-78.9°).  
These values are significantly smaller than the respective bite angles, 81.5° and 86.4°, in 
Re(CO)3(tmbSO2-dipn) (5), as expected from the large six-membered rings in this complex. 
Nevertheless, these angles for 5 are less than that (~89.5°) for Re(CO)3(N,N,N′,N′-tetramethyl-
1,3-propylenediamine)Br.46 Although the methyl groups cause the Re−N bonds to be very long 
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(2.3 Å), the complex also has a very long N to N distance (3.25 Å), explaining the large bite 
angle.   
3.3.1.3 Chirality and Conformation of Chelate Rings. For 1, 2, and 3, the pucker of the 
two chelate rings has different chirality. As mentioned, a different chirality for the pucker of 
each dien chelate ring is found most often.30-32 Because the ligands in this study are 
unsymmetrical, we report chirality combinations by giving the pucker chirality of the ring with 
the terminal amine followed by that of the ring with the sulfonamido group. Also, we specify the 
absolute configuration because the unsymmetrical nature of the ligand creates asymmetric 
central nitrogen (N2) and Re centers. Specifically, this combination for 1-3 is λδ for the 
enantiomer with the S absolute configuration (determined by the absolute configuration at N2, 
Figure 3.3). In contrast, both chelate rings of Re(CO)3(DNS-dien) (4) have pucker with the same 
chirality (both λ for the S configuration). This less-common situation with the same pucker 
chirality for both rings also occurs in the Re(CO)3(LANH) complexes.11 Τhe meridionally 
coordinated ligand in the pseudo square planar Pt(tmbSO2-N,N-Me2dien)Cl complex (work in 
progress), has the δλ chirality combination (S absolute configuration at central N).  
In an early study based on IR data, Schmidtke and Garthoff 33 determined that the δδ or 
λλ combination was the most favorable for facial coordination of diethylenetriamine in 
complexes of several metals (Cr, Co, Rh) and proposed that steric effects of the hydrogens of the 
ethylene chain would also favor the δδ or λλ combination. We compared selected non-bonded 
distances for 1-4 (Table 3.2) involving chelate ring carbons and hydrogens on these carbons 
projecting toward the center of the triangular face occupied by L¯. Whether the pucker chirality 
of the two chelate rings in a given complex is the same or different, the C5 to C6 (Figure 3.4) 
and C5H to C6H distances are not very different. In contrast, when the chirality of the two 
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chelate rings is the same, the C4 to C7 (Figure 3.4) and C4H to C7H distances are larger than 
when the chirality is different. For example, the C4 to C7 distance for 4 (same chirality) is 3.9 Å, 
whereas the respective distance for complexes 1-3 (different chirality) is ~ 2 Å. 
 
Figure 3.4. Illustration of the shorter C4 to C7 non-bonded distances for complexes 1-3 
(different pucker chirality) compared to complex 4 (same pucker chirality). Note the similarity of 
the C5 to C6 non-bonded distances. Also shown are the position of C4 and C5 atoms relative to 
N1−Re−N2 plane (red line), and C6 and C7 atoms relative to N2−Re−N3 (blue line) plane. 
 
It is obvious from Figure 3.4 that the distance from C4 to C7 is much larger when the 
pucker chirality is the same in both rings, as it is in complex 4, compared to when the chirality is 
different. Our observations appear to support the early suggestion of Schmidtke and Garthoff,33 
and the δδ and λλ combinations should be favored. However, later literature surveys31,32 find that 
X-ray structures of complexes more frequently have different chirality in the two rings. In 
particular, one pca study on X-ray structures from the Cambridge Structural Database (CSD) 
showed that 74 fragments had the δλ chirality combination, 16 fragments had the λδ chirality 
combination, 18 fragments had δδ and 18 enantiomeric fragments had the λλ chirality 
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combination.30 This study agreed with earlier pca studies.31,32 This overwhelming evidence for a 
predominance of structures with different pucker chirality is surprising, given that the distances 
between hydrogens or carbons on the two rings (Table 3.2, Figure 3.4) are clearly shorter than 
the sum of the van der Waals radii both for carbon (3.4 Å) and hydrogen (2.4 Å).47 This 
proximity leads to steric repulsion between rings, as suggested by Schmidtke and Garthoff.33 
Additional studies are needed to clarify factors influencing pucker, but at this time it seems 
reasonable to assume in designing radiopharmaceuticals with the 99mTc(CO)3 label that the 
pucker chirality of the rings will be different. 
3.3.2 Solution Behavior 
3.3.2.1 Trimethylbenzyl Group Rotation. In the X-ray structures of the tmb-
sulfonamido complexes (1, 2, 3, and 5) the 3 and 5 protons and the 2 and 6 methyl groups of the 
tmbSO2 group are not equivalent. When modeling software is used to rotate the tmb group 
around the S−C bond, beginning with the solid-state structure of 3, clashes are observed between 
the methyl groups and a CH2 group of the chelate ring. For 3 the distance from C7 to C16 (of the 
CH3 group in position 2) becomes as short as ~1.9 Å, much less than the sum of the van der 
Waals radii for two carbons (3.4 Å).47 The resulting impediment to rotation about the S−C(tmb) 
bond should lead to well separated 1H NMR signals. Indeed, in Re(CO)3(tmbCO-dien, (tmbCO-
dienH = N-[2-(2-aminoethylamino)-ethyl]-2,4,6-trimethylbenzamide, unpublished work), where 
the tmb is linked through a deprotonated amido instead of a sulfonamido group, the 1H NMR 
signals of the 3 and 5 protons and the 2 and 6 methyl groups of the tmbCO group are separate, 
consistent with the expected slow rotation from a similar comparison using modeling software.  
However, even at low temperature, these tmb 1H NMR signals are not resolved for the tmb-
sulfonamido complexes. (The 1H NMR spectrum of 1 (acetone-d6) recorded at -90 °C has no 
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significant difference from the one recorded at 25 °C.) Further examination of the possible 
rotations around the S−C and N3−S bonds in the tmb-sulfonamido complexes reveals that 
concerted rotations about both these bonds can allow the tmb group to rotate more freely. In 
particular, if the N3−S bond is rotated by ~56°, the tmb group can rotate freely around the 
S−C(tmb) bond, and the closest distance between C7 and C16 (of the CH3 group in position 2) is 
~ 3.2 Å; slight changes in bond angles should increase this distance.  
The structures of 1-5 indicate considerable conformational freedom around the N−S 
bond. In contrast, the N−C bond in the relatively planar amido group has more double bond 
character than the N−S bond of the sulfonamido group. These features limit the CO group to 
only two favorable orientations, and in both orientations serious clashes are observed when the 
tmb group is rotated around the C−C(tmb) bond. In addition, the sulfonamido group has longer 
bonds (N−S and S−C) compared to the respective bonds (N−C and C−C) of the amido group in 
Re(CO)3(tmbCO-dien). Therefore, we believe that synchronous rotations about the longer N−S 
and S−C bonds can explain the relatively free rotation of the tmb group, especially because the 
sulfonamide group is known to be in relatively faster rotation than the amide group.48  
3.3.2.2 NMR Characterization of Re(CO)3L (L¯ = tmbSO2-N,N-Me2dien¯, tmbSO2-
N′-Medien¯, tmbSO2-dien¯, DNS-dien¯ and tmbSO2-dipn¯). The Re(CO)3L complexes were 
characterized by NMR spectroscopy (Table 3.3) in different solvents (DMSO-d6, and acetone-
d6). For a given solvent, the shifts of the respective N1H2 and N2H signals were similar in all 
complexes reported here. For complexes 2-5 with a terminal amino group, the NH signals of this 
group have a separation (Δ  ppm) of between 1 to 2 ppm in DMSO-d6. In general, terminal amino 
groups in Pt complexes have two separate signals with Δ ppm between 0.1 to 0.3.26 Specifically, 
in DMSO-d6 the amino groups of 2-5 all have one downfield-shifted NH signal with a normal 
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shift between 5.21 and 5.46 ppm, which is comparable to the shifts (5.11-5.66 ppm) of the 
respective NH signals of the NH2 group in Pt(DNSH-dien)Cl and [Pt(dien)Cl]Cl.26 The upfield-
shifted NH signal of 2-5 is between 3.30-3.59 ppm, which is ~1.5 ppm abnormally upfield 
compared to the NH signals of Pt(II) complexes.  
 
Table 3.3. Selected 1H NMR Chemical Shifts (ppm) of Re(CO)3(tmbSO2-N,N-Me2dien) (1), 
Re(CO)3(tmbSO2-N′Medien) (2), Re(CO)3(tmbSO2-dien) (3), Re(CO)3(DNS-dien) (4), and 
Re(CO)3(tmbSO2-dipn) (5)a 
 Re(CO)3L complex 
 1 2a 3 4a 5a 
           DMSO-d6 
N1HB/Me 2.96 3.30 3.48 3.59 3.30 
N1HA/Me 2.96 5.46 5.22 5.21 5.25 
N2H 6.77  6.76 6.79 5.81 
                    acetone-d6 
N1HB/Me 3.10 3.87 3.98 4.09 4.00 
N1HA/Me 3.11 4.94 4.75 4.77 4.66 
N2H 6.17  6.17 6.23 5.20 
a Assignments of the NH signals of 2, 4 and 5 were made by analogy with signals for 3 
assigned by COSY spectra. 
 
 
An 1H-1H COSY experiment for 3 in combination with torsion angles allowed 
assignment of the NH signals. According to the Karplus equation,49 when the torsion angle 
between two protons is 90°, no coupling is observed between the two protons (3J ≈ 0 Hz); a 
maximum 3J is observed (3J ≈ 9.5 Hz) when the torsion angle is 180°. For Re(CO)3(tmbSO2dien) 
(3), the NH2 signals are correlated by a COSY cross-peak. Also, the downfield N1H signal is 
coupled to both C4H signals, whereas the upfield N1H signal is coupled to only one C4H signal. 
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The H1B–N1–C4–H4B torsion angle is ~80° for 3, predicting a weak N1H1B-C4HB COSY 
cross-peak, whereas the H1A–N1–C4–H4A torsion angle is~ 157° (close to 180°) for 3, 
predicting a strong N1HA-C4HA COSY cross-peak. The H1B–N1–C4–H4A and H1A–N1–C4–
H4B torsion angles are both similar for both compounds and the N1HB-C4HA and N1HA-
C4HB cross-peaks were of similar size. Therefore, the downfield NH2 signal can be identified as 
H1A (anti to the sulfonamido group) and the upfield NH2 signal as H1B. The reasons that the 
NH1A signal for 2-5 has a normal shift and the N1HB signal has an unusually upfield shift are 
unclear, and further investigation is required.  
3.3.2.3 Reactions of Sulfonamido Complexes. Under neutral conditions (DMSO-d6/D2O 
250 µL/550 µL, pH = 7.70) no change was observed in the 1H NMR signals of 3 even after 2 
days.  When a DMSO-d6 solution of 3 (3 mM) was made basic (dien, 10 equiv) no change was 
observed in the 1H NMR signals of 3, even after the solution was heated at ~60 °C for 16 h. 
Thus, 3 is stable under neutral and basic conditions, and a good ligand such as dien did not 
replace the tmbSO2-dien ligand. Within minutes after the sulfonamido complex 3 (4 mM) was 
dissolved under acidic conditions (DMSO-d6/1 M HNO3, 600 µL/20 µL, final [H+] = 0.3 M), the 
1H NMR spectrum was recorded. The sulfonamide NH signal appeared, (7.53 ppm), the N2H 
signal shifted upfield (5.65 ppm), and the N1H signals moved downfield (5.41 and 4.08 ppm). 
Similar results were observed when complex 5 was dissolved in the same acidic conditions; a 
downfield sulfonamide signal appeared (7.76 ppm), the N2H signal (5.29 ppm) as well as the 
N1H signal (5.03 ppm) shifted upfield, the second N1H signal was under the water signal. These 
NMR data indicate that the sulfonamido nitrogen dissociates on protonation and the ligand is 
now bound to the fac-Re(CO)3 moiety in a bidentate fashion through N1 and N2. Bidentate 
binding for the DNS-dienH ligand has been reported in the Pt(DNS-dienH)Cl2 complex.26 
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Comparisons of the 1H NMR spectrum for the latter complex to those obtained for 3 and 5 under 
acidic conditions leave little doubt about the bidentate nature of the products. In these cases, the 
signal of the central NH is substantially upfield in the bidentate ligand compared to the tridentate 
ligand. A similar relationship of the NH shifts has been reported for Re(CO)3 complexes of an N3 
ligand. 
3.4 Conclusions 
The tridentate monoanionic sulfonamido ligands studied here bind to the fac-Re(CO)3 
core, giving an inner coordination sphere with a neutral charge. In strongly acidic conditions the 
sulfonamido group dissociates with protonation, giving a monocationic inner coordination 
sphere. The sulfonamido group in these complexes can act as a potential anchor for 
bioconjugation, indicating that this class of tridentate ligands should be useful in the 
development of radiopharmaceuticals with a 99mTc(CO)3 label. The dangling group connected 
through the sulfonamido bond undergoes free rotation on the NMR time scale, even at low 
temperature. Most complexes reported here have different chirality in each chelate ring, even 
though less severe steric clashes are expected when both chelate rings have the same chirality. 
We find in published and in our ongoing studies that the related amido complexes are much more 
difficult to synthesize, consistent with the paucity of related amido complexes in the literature. In 
contrast, the sulfonamido group has somewhat similar chemistry and more use of this group 
should be made in coordination chemistry. 
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CHAPTER 4. fac-[Re(CO)3L]+ COMPLEXES WITH N-CH2-CH2-X-CH2-CH2-N 
TRIDENTATE LIGANDS. SYNTHETIC, X-RAY CRYSTALLOGRAPHIC AND NMR 
SPECTROSCOPIC INVESTIGATIONS 
 
4.1 Introduction 
Radiopharmaceuticals based on the fac-[99mTc(CO)3]+ core are gaining extensive use 
because the fac-[99mTc(CO)3(H2O)3]+ precursor can be conveniently generated.1-4 Agents with a 
tridentately coordinated ligand (L) of the type, fac-[99mTc(CO)3L], are more robust and have 
better pharmacokinetic profiles than agents bearing mono- or bidentate ligands.5 A recent 
straightforward preparation of aqueous solutions of the non-radioactive fac-[Re(CO)3(H2O)3]+ 
precursor6 has made the synthesis of fac-[Re(CO)3L] analogues convenient and allows 
simulation of the aqueous 99mTc synthetic chemistry.6,7 (Note: All specific complexes mentioned 
in this work have a facial geometry; therefore the fac- designation is used henceforth only for 
referring to a general class of compounds.) The most commonly employed L contain N, O, and S 
as donor atoms from amine,8-10 pyridyl,11 carboxyl8 or thioether6,7 groups. Extensively 
characterized fac-[Re(CO)3L] complexes of a series of symmetric and non-symmetric NNN or 
NSN ligands containing combinations of amine, pyrazolyl, and thioether donors are known.12-14 
During the development of radiopharmaceutical renal agents, polyamino-polycarboxylic acid 
ligands have been investigated.8,15,16 At high pH amine group coordination is preferred, allowing 
for dangling carboxyl groups, which are important in high renal clearance. Other studies 
involving nitrogen, sulfur and oxygen donors have proposed that nitrogen donor ligands are 
better than sulfur donor ligands for fac-[Re(CO)3L] complex formation.11,17  
The location in space of the chelate ring atoms is a key factor in designing fac-
[99mTc(CO)3L] agents because these atoms act as a fulcrum for the pendant groups. In turn, the 
position of the pendant group has a significant effect on the overall shape of the agent and hence 
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on its biological activity. For diethylenetriamine-type ligands bound to a metal center in a 
tridentate fashion, the pucker of the two five-membered chelate rings can have either δ or λ 
chirality (Chart 1), leading to four possible combinations of chelate ring chirality: δλ, λδ, λλ, 
and δδ. X-ray structures from the Cambridge Structural Database (CSD) of [M(dien)2]n+ (M = 
Ni, Co, Zn, Cu, Cr, Rh, and Ir)18 and of [M(dien)Ln]19 complexes and M(dien) fragments20 were 
analyzed by principal component analysis (pca) studies, and the δλ and λδ conformation 
combinations were found more frequently than δδ and λλ combinations.  These results 
contradicted the Schmidtke and Garthoff21 suggestion that a fac-coordinated dien favors a δδ or 
λλ combination because of steric effects of the hydrogen atoms on the ethylene chains. 
Chart 4.1 
 
In a previous study10 we explored the chirality of the ligand pucker in a series of fac-
[Re(CO)3L] complexes with tridentate monoanionic ligands containing the diethylenetriamine 
moiety and an aromatic group connected through a sulfonamide group, such as N-[2-(2-
aminoethylamino)ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dienH) (Chart 2). (The H 
in the ligand names indicates the number of dissociable protons in the ligand and the complex.) 
Our results showed that fac-coordinated sulfonamido ligands have different chirality in each 
chelate ring more frequently than they have the same chirality, in agreement with the pca 
reports.19,20 In contrast, the two chelate rings in the Re analogue of [99mTc(CO)3(LANH)] agents 
(LANH2 = lanthionine, a natural dicysteine-derived dipeptide linked through a common sulfur 
and exhibiting tridentate NSN binding) were found to have the same chirality.7 The 99mTc-tagged 
lanthionine agents were the first small fac-[99mTc(CO)3L] agents reported to have been evaluated 
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in humans;22 thus, additional studies directed at gaining a more comprehensive assessment of 
conformation are warranted. 
Chart 4.2 
 
Normally the two protons of a primary amino group bound to a metal are magnetically 
inequivalent and are expected to have two separate 1H NMR signals with similar shifts. The 
similarity in shifts is understandable because the inductive effects of the surrounding atoms on 
the amine nitrogen should be transmitted nearly equally to the protons. However, in several past 
studies we found unusually upfield- and (in fewer cases) downfield-shifted NH signals for fac-
[Re(CO)3L] complexes with terminal amino groups, (e.g., fac-[Re(CO)3L] complexes of S-
methyl-L-cysteine,6 methionine,6 chiral-LANH2,7 and sulfonamide ligands such as tmbSO2-
dienH),10 whereas in some other cases (e.g., fac-[Re(CO)3L] complexes of meso-LANH2 and 
ethylenediamine-N-acetic acid, ENACH) the NH signals had similar shifts. The tridentate ligand 
in [Re(CO)3(ENDAC)]- (ENDACH2 = ethylenediamine-N,N′-diacetic acid, Chart 2) binds 
through a terminal amine group (NHCH2CO2-) and a secondary NH group anchoring two chelate 
rings. Two isomers were crystallized, one with an endo-NH proton (pointing toward the carbonyl 
groups) and the other with an exo-NH proton (pointing away from the carbonyl groups).8 In this 
study, we have examined fac-[Re(CO)3L] complexes with less elaborate prototypical ligands, 
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ones lacking large pendant substituents, in order to establish base-line behavior and thereby 
define parameters useful for assessing the effects of the pendant groups. These unusual shifts 
have led us to investigate the interaction of the complex with solvent as well as with the chloride 
anion.  Such an investigation can be viewed as creating a very preliminary set of empirical 
observations relevant to the very difficult problem of predicting biodistribution, which is 
influenced by interactions of the agent with the solvent and the anions present in the media. 
4.2 Experimental Section 
4.2.1 Starting Materials 
Diethylenetriamine (dien), N,N′,N′′-trimethyldiethylenetriamine (N,N′,N′′-Me3dien), 
N,N,N′,N′′,N′′-pentamethyldiethylenetriamine (N,N,N′,N′′,N′′-Me5dien), and Re2(CO)10 from 
Aldrich, N,N-dimethyldiethylenetriamine (N,N-Me2dien) from Ames Laboratories, and N-
methyl-2,2′-diaminodiethylamine (N′-Medien) and 2,2′-diaminodiethyl sulfide (daes) from TCI 
America were all used as received. [Re(CO)3(H2O)3]OTf (OTf = trifluoromethanesulfonate)6 and 
[Pt(dien)Cl]Cl23 were prepared by known methods. 
4.2.2 Physical Measurements 
4.2.2.1 NMR Spectroscopy. 1H NMR spectra were recorded on either a 300 MHz or 400 
MHz spectrometer.  Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference.  All NMR data were processed with XWINNMR and Mestre-C software.  
4.2.2.2 X-ray Data Collection and Structure Determination. Single crystals were 
placed in a cooled nitrogen gas stream at ~100 K on a Nonius Kappa CCD diffractometer fitted 
with an Oxford Cryostream cooler with graphite-monochromated Mo Kα (0.71073 Å) radiation. 
Data reduction included absorption corrections by the multi-scan method, with HKL 
SCALEPACK.24 All X-ray structures were determined by direct methods and difference Fourier 
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techniques and refined by full-matrix least squares, using SHELXL97.25 All non-hydrogen atoms 
were refined anisotropically. All hydrogen atoms were visible in difference maps, but were 
placed in idealized positions. A torsional parameter was refined for each methyl group.  
4.2.3 Synthesis of fac-[Re(CO)3L]+ 
4.2.3.1 fac-[Re(CO)3L]PF6 and fac-[Re(CO)3L]BF4. An aqueous solution of 
[Re(CO)3(H2O)3]OTf (10 mL, 0.1 mmol) was treated with LH (0.1 mmol). The pH was adjusted 
to ~6, and the reaction mixture was heated at reflux for 10 h. The reaction mixture was allowed 
to cool to room temperature and the volume was reduced to 5 mL by rotary evaporation. Solid 
NaPF6 or NaBF4 was added, and the white precipitate that formed was collected on a filter, 
washed with ether, and dried under vacuum. X-ray quality crystals were obtained from the 
filtrate or by slow evaporation from an acetone solution. 
4.2.3.2 [Re(CO)3(dien)]PF6 (1a). Treatment of the [Re(CO)3(H2O)3]+ (0.1 mmol) 
solution with dien (10 μL) as described above afforded [Re(CO)3(dien)]PF6 as a white powder 
(10 mg, 27% yield) after the addition of NaPF6 (10 mg). The product was characterized by single 
crystal X-ray crystallography. 1H NMR spectrum (ppm) in DMSO-d6: 6.98 (b, 1H, NH), 5.43 (b, 
2H, NH), 4.13 (b, 2H, NH), 2.83 (m, 4H, CH2), 2.70 (m, 4H, CH2). 
4.2.3.3 [Re(CO)3(dien)]BF4 (1b). Treatment of the [Re(CO)3(H2O)3]+ (0.1 mmol) 
solution with dien (10 μL) as described above afforded [Re(CO)3(dien)]BF4 as a white powder (9 
mg, 19% yield) after the addition of NaBF4 (10 mg). The product was characterized by single 
crystal X-ray crystallography. 1H NMR spectrum (ppm) in DMSO-d6: identical to that of 1a. 
4.2.3.4 [Re(CO)3(N′-Medien)]4(PF6)3(SO3CF3) (2). Treatment of the [Re(CO)3(H2O)3]+ 
(0.1 mmol) solution with N′-Medien (12 μL) as described above afforded [Re(CO)3(N′-
Medien)]PF6 as a white powder (17 mg, 44% yield) after the addition of NaPF6 (10 mg). The 
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product was characterized by single crystal X-ray crystallography. 1H NMR (ppm) spectrum in 
DMSO-d6: 5.59 (b, 2H, NH), 4.17 (b, 2H, NH), 3.13 (s, 3H, CH3), 3.08 (m, 2H, CH2), 2.92-2.66 
(m, 6H, CH2). 
4.2.3.5 [Re(CO)3(N,N-Me2dien)]PF6 (3). Treatment of the [Re(CO)3(H2O)3]+ (0.1 
mmol) solution with N,N-Me2dien (13 μL) as described above afforded [Re(CO)3(N,N-
Me2dien)]PF6 as a white powder (15 mg, 38% yield) after the addition of NaPF6 (10 mg). The 
product was characterized by single crystal X-ray crystallography. 1H NMR (ppm) spectrum in 
DMSO-d6: 7.02 (b, 1H, NH), 5.68 (b, 1H, NH), 4.28 (b, 1H, NH), 3.06 (s, 3H, CH3), 2.95 (m, 
4H, CH2), 2.76 (s, 3H, CH3), 2.75 (m, 4H, CH2). 
4.2.3.5 meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4). Treatment of the 
[Re(CO)3(H2O)3]+ (0.1 mmol) solution with N,N′,N′′-Me3dien (15 μL) as described above 
afforded the meso-exo isomer of [Re(CO)3(N,N′N′′-Me3dien)]PF6 as colorless crystals (9 mg, 
22% yield) after the addition of NaPF6 (10 mg). The product was characterized by single crystal 
X-ray crystallography. 1H NMR (ppm) spectrum in DMSO-d6: 5.22 (b, 2H, NH), 3.18 (s, 3H, 
CH3), 2.97 (m, 4H, CH2), 2.95 (d, 6H, CH3), 2.77 (m, 2H, CH2). 
4.2.3.6 Solids with the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ cation. Treatment of the 
[Re(CO)3(H2O)3]+ (0.1 mmol) solution with N,N,N′,N′′,N′′-Me5dien (18 μL) as described above 
followed by addition of NaBF4 (10 mg) or of NaPF6 (10 mg) afforded, respectively, colorless 
crystals of [Re(CO)3(N,N′,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)4]⋅3.35H2O (5) from x-ray 
(10 mg, 36% yield) and a white powder of [Re(CO)3(N,N′,N′,N′′,N′′-Me5dien)]PF6 (5a) (15 mg, 
23% yield). 5a was recrystallized from acetone, and both crystal types were characterized by 
single crystal X-ray crystallography. 1H NMR (ppm) spectrum of 5a in DMSO-d6: 3.23 (s, 6H, 
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CH3), 3.21 (m, 4H, CH2), 3.19 (s, 3H, CH3), 3.06 (m, 2H, CH2), 2.93 (m, 2H, CH2), 2.81 (s, 6H, 
CH3). 
4.2.3.7 [Re(CO)3(daes)]PF6 (6). Treatment of the [Re(CO)3(H2O)3]+ (0.1 mmol) solution 
with daes (10 μL) as described above afforded [Re(CO)3(daes)]PF6 as crystals (10 mg, 20% 
yield) after the addition of NaPF6 (10 mg). The product was characterized by single crystal X-ray 
crystallography. 1H NMR (ppm) spectrum in DMSO-d6: 5.55 (b, 2H, NH), 4.22 (b, 2H, NH), 
2.94 (m, 2H, CH2), 2.75 (m, 6H, CH2). 
4.3 Results and Discussion 
4.3.1 X-Ray Characterization  
  All complexes exhibit a distorted octahedral structure, with the three carbonyl ligands 
occupying one face. The remaining coordination sites are occupied by three amines for 
complexes 1 to 5 (Figure 4.1) and two amine nitrogens and a thioether sulfur for 6 (Figure 4.2). 
Crystal data and details of the structure refinement for complexes 1 to 6 are summarized in Table 
4.1. The Re−N and Re−S bond lengths and the N−Re−N and S−Re−N angles (see Table 4.2 for 
selected bond lengths and angles) are comparable to values of relevant complexes containing 
amine and thioether groups.6,7,9,10 Because of the longer Re−S (~2.2 Å) and C−S (~1.8 Å) bonds 
compared to the Re−N (~2 Å) and C−N (~1.4 Å) bonds, the S−Re−N chelate ring bite angles and 
the N to S and C5 to C6 non-bonded distances are larger in 6 compared to the respective 
parameters in 1 to 5, Table 4.3.  However, near the terminal amines, the structure becomes more 
similar for the NSN vs. the NNN compounds as illustrated in Appendix C.  The implication of 
this result is that pendant groups on terminal amines should project outward in a similar manner 
for both types of chelates, whereas pendant groups on the carbons adjacent to the donor atom 
anchoring the two chelate rings will project in a very different manner.  
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Figure 4.1. Perspective drawings of [Re(CO)3(dien)]PF6 (1a), [Re(CO)3(dien)]BF4 (1b), 
[Re(CO)3(N′-Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-
[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4), [Re(CO)3(N,N,N′,N′′,N′′-
Me5dien)]OTf⋅[Re(CO)3(µ3-OH)]4⋅3.35H2O (5) and [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf (5a). 
Counter ions are omitted for clarity. Thermal ellipsoids are drawn with 50% probability. 
 
 
Figure 4.2. Perspective drawing of [Re(CO)3(daes)]PF6 (6). The counter ion is omitted for 
clarity. Thermal ellipsoids are drawn with 50% probability. 
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Table 4.1. Crystal Data and Structure Refinement for [Re(CO)3(dien)]PF6 (1a), [Re(CO)3(dien)]BF4 (1b), [Re(CO)3(N′-
Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4), 
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)]4⋅3.35H2O (5) and [Re(CO)3(daes)]PF6 (6) 
 1a 1b           2 3 meso-exo-4 5 6 
formula C7H13N3O3
RePF6 
C7H13N3O3Re
BF4 
4(C8H15N3O3Re
)(CF3O3S)(PF6)3 
C9H17N3O3Re
PF6 
C10H19N3O3ReP
F6 
C12H23N3ReS(CF3
O3S)(C12H4O16Re4
)3.35(H2O) 
C7H12N2O3
ReSPF6 
fw 518.37 460.21 2133.70 436.43 560.45 588.50 535.42 
crystal 
system 
orthorhom
bic 
monoclinic monoclinic orthorhombic monoclinic triclinic orthorhombi
c 
space group Pna21 Cm Pc P212121 P21/c 1P  Pna21 
a (Å) 16.396 (2) 9.566 (2) 11.4999 (6) 8.6289 (10) 14.6964 (15) 9.6358 (10) 12.3209 (12) 
b (Å) 8.5554 (10) 10.267 (3) 11.6824 (9) 12.0976 (13) 13.2755 (12) 15.0396 (15) 8.3770 (10) 
c (Å) 9.7512 (12) 8.010 (2) 22.8706 (15) 15.363 (2) 17.146 (2) 15.4932 (15) 14.1136.7 (3) 
β (°) 90 125.730 (11) 90.145 (4) 90 91.165 (4) 98.815 (5) 90 
V (Å3) 1367.8 (3) 638.6 (3) 3072.6 (3) 1603.7 (3) 3344.5 (6) 2208.2 (4) 1456.7 (3) 
T (K) 90 173 90 90 90 90 90 
Z 4 2 2 4 8 2 4 
ρcalc (mg/m3) 2.517 2.393 2.306 2.263 2.226 2.710  2.441 
abs coeff 
(mm-1) 
9.084 9.570 8.096 7.754 7.440 13.80 8.670 
2θmax (°) 72.8 73.6 71.2 80.4 74.0 37.4 73.6 
R indicesa 0.027 0.047 0.036 0.048 0.042 0.036 0.054 
wR2 = [I> 
2σ(I)]b 
0.063 0.063 0.083 0.057 0.092 0.087 0.072 
data/param 6131/192 2578/99 26464/804 9946/221 15639/452 16677/570 6569/192 
aR = (∑||Fο| - |Fc||)/∑|Fο|; bwR2 = [∑[w(Fο2 - Fc2)2]/∑[w(Fο2)2]]1/2 
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Table 4.2. Selected Bond Distances (Å) and Angles (deg) for [Re(CO)3(dien)]PF6 (1a), [Re(CO)3(dien)]BF4 (1b), [Re(CO)3(N′-
Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4), 
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)]4⋅3.35H2O (5) and [Re(CO)3(daes)]PF6 (6)a 
 
 1a 1b 2 3 meso-exo-4 5 6a 
bond distances 
Re–N1 2.238 (3) 2.213 (8) 2.197 (5) 2.240 (2) 2.233 (3) 2.233 (5) 2.243 (5) 
Re–N2 2.201 (3) 2.222 (8) 2.250 (4) 2.205 (2) 2.238 (3) 2.230 (4) 2.4737 (10)a 
Re–N3 2.244 (3)   2.215 (5) 2.265 (2) 2.220 (3) 2.295 (4) 2.226 (3)a 
bond angles 
N1–Re–N2 77.50 (12) 77.9 (3) 78.84 (18) 77.28 (9) 79.62 (13) 78.93 (16) 80.15 (9)a 
N2–Re–N3 76.56 (12) 77.9 (3) 77.20 (17) 78.65 (9) 77.91 (13) 79.38 (15) 81.06 (12)a 
N1–Re–N3 87.14 (12) 87.6 (6) 87.8 (2) 91.21 (9) 86.70 (14) 99.15 (16) 85.7 (2)a 
 
a For 6, parameters involving S and N2 are placed in the rows containing N2 and N3 values, respectively. 
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The length of the Re−N bonds depends on the number and size of the substituents 
replacing the ligand NH groups. The Re−N bonds in complexes in which N1 and N3 have two 
methyl substituents (3 and 5) are significantly longer than any of the other Re−N bonds in 1 to 4, 
in which N1, N2 and N3 have at most one methyl substituent replacing an H atom. This 
lengthening is attributed to the bulkiness of the methyl groups compared to the smaller H group. 
When the amine group has only one methyl group as a substituent, the Re−NHCH3 bonds are 
numerically but not significantly longer than the Re−NH2 bonds. For both the endo and exo 
Re(CO)3(ENDACH) complexes (which crystallize as neutral complexes),8 the 
Re−NHCH2COOH bonds are significantly longer than the Re−NH2 bond of Re(CO)3(ENAC)8 
and the Re−NH2 bonds of the complexes presented here. It is evident that a single methyl group 
substituent on an amine group probably does not have enough bulk to cause significant 
lengthening of Re−N bonds, whereas larger substituents (e.g., CH2COOH in 
Re(CO)3(ENDACH) in the solid state) or two substituents (e.g., two methyl groups in 3 and 5) 
have sufficient bulk to make the Re−N bonds significantly longer.  
In the solid state of 1b and 6, intermolecular hydrogen bonding is observed between the 
N2H or N1H2 (cf. Figures 4.1 and 4.2 for numbering) and a carbonyl group of another molecule 
in the unit cell (N to O distance = 3.03 Å for 1b and 2.96 Å for 6). In complex 2, hydrogen 
bonding is observed between the N1H2 group and the OTf counter ion (N to O distance = 2.87 
Å). No hydrogen bonding was observed in the solid-state structures of 1a, 3, 4 and 5. In the 
[Re(CO)3(dien)]Br crystal, intermolecular hydrogen bonding was observed between one Br¯ 
counter anion and a terminal NH2 group and a central NH of two separate cations.9  
4.3.1.1 [Re(CO)3(dien)]X. The [Re(CO)3(dien)]Br salt just mentioned was prepared from 
(NEt4)2[ReBr3(CO)3];9 however, because [Re(CO)3(dien)]+ serves as an important prototypical 
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model complex for elaborated tridentate amine ligands, we synthesized the [Re(CO)3(dien)]+ 
complex by using [Re(CO)3(H2O)3]OTf as a precursor and crystallized both the PF6¯ (1a) and 
the BF4¯ (1b) salts. The dien ligand has different chirality in each chelate ring of 
[Re(CO)3(dien)]Br and [Re(CO)3(dien)]BF4, but the same chirality in [Re(CO)3(dien)]PF6. The 
crystal structure of [Re(CO)3(dien)]Br contains two similar but independent cations in the 
asymmetric unit. Overlaying of these two cations with [Re(CO)3(dien)]BF4 (1b) gave RMS = 
0.0101 and 0.0125 (from overlaying the Re, N1, N2, and N3 atoms). In contrast, overlaying of 
these two cations with [Re(CO)3(dien)]PF6 (1a) gave RMS = 0.0384 and 0.0378. The fit between 
1a and [Re(CO)3(dien)]Br seems to be less good than that of 1b and [Re(CO)3(dien)]Br; such a 
finding can be explained because the chirality of the pucker of the two chelate rings is different 
in [Re(CO)3(dien)]Br and 1b, whereas the chirality of the pucker of the two chelate rings is the 
same in [Re(CO)3(dien)]PF6 (1a). 
 
 
Figure 4.4. Designation of rings A and B when the structure shown in the ORTEP is viewed 
with the non-chelate ring substituent on N2 projecting away from the viewer. Also depicted are 
the endo-NH protons (pointing toward the carbonyl groups) and the exo-NH protons (pointing 
away from the carbonyl groups). 
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4.3.1.2 Solids with the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ Cation. The structure of 
the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]PF6 (5a) salt was disordered and did not allow analysis of 
the chirality of the chelate rings. Therefore, we chose to report the crystallographic data and to 
seek another salt for obtaining information on chelate ring pucker. We isolated and characterized 
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(µ3-OH)]4⋅3.35H2O (5). The [Re(CO)3(µ3-
OH)]4 cubane-type cluster is well known to form in solutions of [Re(CO)3(H2O)3]+ at high pH.26 
In the unit cell, the carbonyl groups of the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ cation are 
oriented toward the carbonyl groups of one of the Re atoms of the cluster with O to O non-
bonding distances as close as 3.101 Å (Figure 4.3). The CSD contains many examples of this 
cluster but none have a co-crystallized Re(I) complex.   
 
 
Figure 4.3. View of the relative orientations of the [Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]+ cation 
and the neutral [Re(CO)3(µ3-OH)]4 molecule in the crystal of 5, showing the interactions of the 
CO ligands depicted in the space filling-mode.  
 
4.3.1.3 Chirality and Conformation of Chelate Rings. The two rings formed upon dien 
binding are designated as A (left ring) and B (right ring) in Figure 4.4.  Throughout the text and 
in Table 4.3 we report chirality combinations by giving the pucker chirality of ring A followed 
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by that of ring B for the ORTEP structures shown in Figure 4.1. The two chelate ring puckers of 
2 to 6 have the same chirality, as found for 1a. Thus, only the 1b structure has different pucker 
chirality in each of the two chelate rings, which is the combination most commonly observed. 
The case of both rings having the same pucker chirality was observed in the [Re(CO)3(meso-
LANH)] and [Re(CO)3(chiral-LANH)] complexes7 and in the sulfonamido [Re(CO)3(DNSH-
dien)] complex (DNSH-dienH = N-(2-((2-aminoethyl)amino)ethyl)-5-
(dimethylamino)naphthalene-1-sulfonamide).10  Τhe meridionally coordinated ligand in the 
pseudo square planar complex, [Pt(dien)Cl]Cl,27 has the λδ chirality combination.  It is obvious 
from Table 4.3 that the distance from C4 to C7 is much larger when the pucker chirality is the 
same in both rings, as it is in complexes 1a and 2 to 6, compared to when the ring chirality is 
different, as it is in 1b and [Re(CO)3(dien)]Br. The distances between hydrogens or carbons on 
the two rings when the rings have the same chirality are shorter than the sum of the van der 
Waals radii for both carbon (3.4 Å) and hydrogen (2.4 Å).28 This proximity should cause steric 
repulsion between rings, as suggested by Schmidtke and Garthoff,21 and their suggestion that the 
δδ and λλ combinations should be favored in fac coordination of the dien ligand seems to be 
supported by our observation. However, pca analyses of X-ray structures of complexes18,19 find 
that complexes have different chirality in the two rings more frequently. These analyses were 
supported by a more recent pca study20 showing that 74 fragments had the δλ chirality 
combination, 16 fragments had the λδ chirality combination, 18 fragments had δδ and 18 
enantiomeric fragments had the λλ chirality combination.  
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Table 4.3. Selected non-bonded distances (ppm) for [Re(CO)3(dien)]PF6 (1a), 
[Re(CO)3(dien)]BF4 (1b) [Re(CO)3(N′-Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-
Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4), 
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]OTf⋅[Re(CO)3(μ3-OH)]4⋅3.35H2O (5) and 
[Re(CO)3(daes)]PF6 (6) 
Complex Pucker C5H-C6H C5-C6 C4H-C7H C4-C7 
N1-N2 
or N1-S 
N2-N3 or 
N2-S 
[Re(CO)3(dien)]Br λδ 2.290 2.514 2.119 3.279 2.790 2.788 
1a λλ 2.389 2.478 4.009 3.963 2.754 2.780 
1b λδ 2.296 2.524 2.080 3.281 2.787  
2 δδ 2.487 2.461 4.272 3.999 2.812 2.797 
3 λλ 2.485 2.493 4.153 4.029 2.775 2.833 
meso-exo-4 λλ 2.419 2.458 4.011 3.937 2.840 2.826 
5 δδ 2.390 2.459 4.128 4.054 2.890 2.902 
6 λλ 2.616 2.683 3.945 4.010 3.070 3.032 
 
4.3.1.4 [Re(CO)3(N,N′,N′′-Me3dien)]+ Isomers. Three [Re(CO)3(N,N′,N′′-Me3dien)]+ 
isomers are conceivable (Figure 4.4). The protons on the terminal amines can be endo (near the 
carbonyl ligands in the basal plane) or exo (away from the carbonyl ligands), giving the meso-
endo isomer (in which both protons point near the carbonyl ligands), the chiral isomer (in which 
one methyl group points toward and the other away from the carbonyl ligands), and the meso-exo 
isomer (in which both protons point away from the carbonyl ligands). The synthesis afforded a 
mixture of the meso-exo (meso-exo-4) and the chiral (chiral-4) isomers, but only the meso-exo 
isomer was isolated in crystalline form and characterized by X-ray crystallography.  
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Figure 4.4. Possible isomers for [Re(CO)3(N,N′,N′′-Me3dien)]+. 
 
4.3.2 NMR Spectroscopy 
The [Re(CO)3L]+ complexes reported here were characterized by NMR spectroscopy 
(Table 4.4) in different solvents (DMSO-d6, acetone-d6, acetonitrile-d3). For a given solvent, the 
shifts of the respective terminal NH2 and central NH signals were similar for all of these 
complexes. For complexes with terminal primary amino groups (1, 2, 3, and the previously 
reported [Re(CO)3(DNSH-dien)]10), the NH signals of this group have a chemical shift 
separation (Δ ppm) of 1 to 1.5 ppm in DMSO-d6. This separation is caused primarily by the fact 
that one of the NH signals is unusually upfield. The [Re(CO)3(chiral-LANH)] complex has two 
NH2 groups; one group has NH signals with normal chemical shifts of 5.44 and 5.10 ppm (Δ 
ppm = 0.34) (similar to those of the [Re(CO)3(meso-LANH)] complexes), whereas the other NH2 
group has one unusually upfield (3.92 ppm) and one downfield (6.19 ppm) NH signal (Δ ppm = 
2.2). In general, terminal amino groups in Pt and Pd complexes have two signals with a Δ ppm 
ranging from 0.1 to 0.4.29,30 Thus, in DMSO-d6 the relatively downfield NH signal of the amino 
groups of 1 to 3 all fall in a normal shift range between 5.43 and 5.68 ppm, which is comparable 
to the shifts (5.11 to 5.66 ppm) of the respective NH signals of the NH2 groups in [Pt(DNSH-
dien)Cl] and [Pt(dien)Cl]Cl.29 Complexes 3 and 5, which contain a dimethylamino group, have 
meso-exo chiral meso-endo 
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two methyl signals with a separation of ~0.3 to 0.5 ppm in DMSO-d6. In acetone-d6 the 
separation of the methyl signals of 5 is 0.36 ppm, and both the chemical shift and the separation 
of the two methyl signals of the Me5dien ligand were comparable to those of the 
[Pt(Me5dien)I]2Pt2I6 complex (Δ ppm = 0.17 ppm).31 The upfield shift effect appears to be 
generally limited to a particular type of NH group. 
 
Table 4.4. Selected Chemical Shifts (ppm) for [Re(CO)3(dien)]+ (1), [Re(CO)3(N′-
Medien)]4(PF6)3(SO3CF3) (2), [Re(CO)3(N,N-Me2dien)]PF6 (3), meso-exo-[Re(CO)3(N,N′,N′′-
Me3dien)]PF6 (meso-exo-4), chiral-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (chiral-4), 
[Re(CO)3(N,N,N′,N′′,N′′-Me5dien)]PF6 (5a) and [Re(CO)3(daes)]PF6 (6) in various solvents 
 
 fac-[Re(CO)3L]+ complex 
 dien N′-Medien 
N,N-
Me2dien 
N,N′,N′′-
Me3dien 
chiral 
N,N′,N′′-
Me3dien 
meso-exo 
N,N,N′,N′′,N′′
-Me5dien 
daes 
DMSO-d6        
exo-N1H/Me 4.14 4.17 4.28/2.76 5.15/2.66 5.15 2.82 4.22 
endo-N1H/Me 5.43 5.59 5.68/3.06 6.39/2.94 2.94 3.23 5.54 
N2H/Me 6.98 3.13 7.02 3.15 3.18 3.19  
acetone-d6        
exo-N1H/Me 4.40 4.37 4.27/3.01 4.74/2.99 5.02 3.08 4.41 
endo-N1H/Me 5.22 5.42 5.54/3.30 6.03/3.21 3.21 3.44 5.43 
N2H/Me 6.57 3.39 6.64 3.40 3.44 3.43  
acetonitrile-d3        
exo-N1H/Me 3.35 3.39 3.25/2.73 3.85/2.72 4.06 2.84 3.39 
endo-N1H/Me 4.32 4.43 4.58/3.13 5.04/3.02 3.03 3.27 4.37 
N2H/Me 5.57 3.22 5.53 3.21 3.24 3.24  
 
4.3.2.1 meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4). The isomerically pure 
meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 salt in DMSO-d6 has one set of 1H NMR signals that 
included one relatively upfield NH signal (integrating to 2H) at 5.15 ppm (typical chemical shift 
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for secondary amine NH = ~7 ppm) and one methyl doublet (2.94 ppm). The spectrum remained 
unchanged even after two days. As mentioned above, a mixture of the meso-exo and the chiral 
isomer of [Re(CO)3(N,N′,N′′-Me3dien)]PF6 (ratio 1:1) was also isolated in the synthesis. The 1H 
NMR spectrum (DMSO-d6) of this mixture reveals a relatively downfield (6.39 ppm) small NH 
signal and a relatively upfield (5.15 ppm) large NH signal, which are respectively assigned to the 
endo-NH of chiral-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 (chiral-4) and  to overlapping signals of the 
exo-NH of chiral-4 and the two exo-NH’s of meso-exo-4. 
Sodium hydroxide was added to a DMSO-d6 solution (5 mM, 600 µL) of the isolated 
meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 complex in order to catalyze isomerization at N1 or 
N3 of the meso-exo isomer (meso-exo-4) for conversion to other isomers. Upon addition of base 
(DMSO-d6/0.04 M NaOH, 600 µL/10 µL, final [OH-] = 0.6 mM), a new set of signals, belonging 
to a new isomer, appeared within minutes, and the NH signal of meso-exo-4 shifted slightly 
downfield to 5.26 ppm. The intensities of the new signals continued to increase for ~2 h, and the 
final ratio of the signals of the new isomer to those of the meso-exo isomer was 1:2 (the sample 
was then monitored for 5 months and no further change was observed). The new set of signals 
included one downfield (6.39 ppm) and one relatively upfield (5.13 ppm) NH signal (for a 
secondary amine) and one relatively downfield (2.90 ppm) and one relatively upfield (2.66 ppm) 
methyl doublet signal. In a 1H-1H COSY NMR experiment (Appendix C), the relatively 
downfield NH signal gave a cross-peak to the relatively upfield methyl signal, while the 
relatively upfield NH signal gave a cross-peak to the relatively downfield methyl signal. These 
cross-peaks allowed the assignment of the new signals to the chiral isomer. By analogy to these 
assignments for the [Re(CO)3(N,N′,N′′-Me3dien)]+ isomers, we can assign the unusually upfield 
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NH signal in the spectra of complexes 1 to 3 to the exo-NH and the relatively downfield NH 
signal to the endo-NH. 
Isomerization of a secondary amine group bound to a Re(CO)3 moiety at high pH was 
also observed for [Re(CO)3(ENDAC)]-.8 The terminal amine substituents are a proton and a 
dangling acetyl group (CH2CO2-). Both isomers were isolated as the neutral Re(CO)3(ENDACH) 
complex. The NH signal of the endo isomer had a chemical shift at 5.84 ppm, whereas the exo 
isomer had an NH signal at 5.34 ppm in DMSO-d6. Even though the difference in shift of the two 
signals is not so large as the difference in shift of the signals of chiral-4, the signal assignment is 
still consistent with our assignment that the exo-NH is the relatively upfield signal and the endo-
NH is the relatively downfield signal. 
As described above, upon addition of base to a DMSO-d6 sample containing the pure 
meso-exo isomer of [Re(CO)3(N,N′,N′′-Me3dien)]PF6 (meso-exo-4), the exo-NH signal of this 
starting meso-exo-4 complex moved downfield, and isomerization at a terminal amine group 
occurred. When only H2O was added to such a DMSO-d6 sample, the meso-exo-4 exo-NH signal 
did not shift. The effect of base was also studied with a DMSO-d6 solution of the isolated non-
crystalline mixture of [Re(CO)3(N,N′,N′′-Me3dien)]PF6 (5 mM, 600 µL, meso-exo-4 to chiral-4 
isomer ratio 1:1). Upon addition of base (DMSO-d6/0.1 M NaOH, 600 µL/10 µL, final [OH-] = 
1.7 mM) only the exo-NH signal of meso-exo-4 shifted downfield by ~0.5 ppm, whereas the NH 
signals of the chiral-4 remained unchanged. In an essentially identical base addition experiment 
with [Re(CO)3(dien)]PF6, no NH signal shift change was observed.  
The downfield shift observed for the exo-NH signal of the meso-exo isomer of 
[Re(CO)3(N,N′,N′′-Me3dien)]PF6 upon addition of NaOH might be related to the fact that the two 
exo-NH groups of meso-exo-4 project in the same direction and are relatively fixed in position 
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by the endo-Me groups. The chiral-4 isomer has one endo and one exo NH and the NH’s of 
[Re(CO)3(dien)]PF6 may not be at a fixed position because chelate rings are conformationally 
dynamic. These considerations lead us to suggest that the relatively selective shift effect for 
meso-exo-4 could be the result of a hydroxo/water solvation cluster bridging the two NH’s. In 
addition, the absence of such a cluster for the dien complex could be caused by the difference in 
solvation of the primary amines vs. the secondary amines in meso-exo-4.   
4.3.2.2 Interaction of NH Protons with Cl¯ Anion. Understanding the basis of the very 
different NH shifts of the fac-[Re(CO)3L] complexes is a challenge. The shift difference we 
observe could arise from different exposure of the NH group to solvent. To test this possibility 
we added Cl¯ to DMSO-d6 solutions of representative complexes. This anion is known to form 
H-bonds in non-aqueous solvents. If any H-bonding occurs between NH and Cl¯, we would 
expect the NH signal to shift downfield.32,33 
Indeed, when Cl¯ (1 to ~175 mM) was added to a solution of [Re(CO)3(dien)]+ (5 mM, 
DMSO-d6), the upfield NH signal assigned to the exo-NH groups shifted downfield (Δδ ~ 1.2 
ppm) and reached a plateau at ~100 mM of Cl¯, whereas the downfield NH signals assigned to 
the endo-NH’s and the central N2H remained relatively unchanged. Figure 4.5 shows the change 
in chemical shift (Δδ) vs. the amount of Cl¯ added. Even after the addition of more Cl¯, the 
endo-NH and the central N2H signals do not change significantly. In a similar experiment with 
[Re(CO)3(daes)]PF6 (6) (2.6 mM, DMSO-d6), upon Cl¯ addition the final Δδ observed was 0.9 
ppm (at 100 mM) for the exo-NH signal giving a final shift of 5.13 ppm for the 
[Re(CO)3(daes)]+, Cl¯ ion pair, a value relatively close to the 5.33 ppm observed for the exo-NH 
signal [Re(CO)3(dien)]+,Cl¯ ion pair.  
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Figure 4.5. Change in chemical shift (Δδ) of exo-NH, endo-NH and N2H signals of 
[Re(CO)3(dien)]PF6 upon addition of Cl¯ in DMSO-d6. 
 
Behavior similar to that of [Re(CO)3(dien)]PF6 was observed when Cl¯ (1 to ~175 mM) 
was added to a solution of an isomeric mixture of meso-exo-4 and chiral-4 (5 mM, DMSO-d6). 
The exo-NH signal of meso-exo-4 shifted downfield (Δδ between the final and initial chemical 
shifts ~1.5 ppm) and the relatively upfield exo-NH signal of chiral-4 shifted downfield (Δδ ~ 1.1 
ppm).  However, the relatively downfield endo-NH signal of chiral-4 shifted downfield 
minimally (Δδ ∼ 0.25 ppm). Small changes were also observed in the CH signal of the ethylene 
chains.  
Assuming that the final ion pair has a 1:1 ratio, we calculated from the data used to plot 
Figure 4.5 and figures in Appendix C equilibrium constants of 93 ± 5 M-1 for 
[Re(CO)3(dien)]+,Cl¯; 96 ± 11 M-1 for [Re(CO)3(daes)]+,Cl¯; and 56 ± 8 and 239 ± 23 M-1 for 
chiral- and meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]+,Cl¯ ion pairs, respectively. The significantly 
higher binding constant for meso-exo-4, compared to those of 1 and chiral-[Re(CO)3(N,N′,N′′-
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Me3dien)]+ might be attributed to the fixed location of the exo-NH’s of meso-exo-4, as discussed 
above.  
In contrast to the above results, when Cl¯ was added to solutions of complexes that have 
only one terminal NH2 group, the exo-NH did not appear to interact strongly with Cl¯. 
Specifically, when as much as 80 mM Cl¯ was added to 5 mM DMSO-d6 solutions of 
[Re(CO)3(N,N-Me2dien)]PF6 and of Re(CO)3(DNS-dien),10 no significant NH shift change was 
observed. Obviously, it is necessary to have at least one NH in each terminal amine group for H-
bonding with Cl¯ to occur. Only small changes in shift of the endo-NH, N2H and CH signals of 
1, meso-exo-4, and chiral-4 were observed, and these are attributable to non-specific salt or ionic 
strength effects. On the other hand, the downfield shift by at least 1 ppm of the exo-NH signals 
of 1, meso-exo-4, and chiral-4, attributable to NH - - Cl¯ hydrogen bonding within the ion pair, 
correlates roughly with the magnitude of the equilibrium constant. These findings indicate that 
the Cl¯ indeed interacts with the two exo-NH’s in complexes 1, meso-exo-4, and 6, and are 
consistent with the ion pair model for H-bonding between Cl¯ and the exo-NH’s proposed in 
Figure 4.6. The distances of the Cl¯ ion to N1 and N2, 3.258 and 3.289 Å, respectively, are very 
similar to the distances observed in the solid state for fac-[Pt(IV)(dien)Cl3]Cl,34 where the Cl¯ 
counter ion was H-bonded to the two terminal NH2 groups with Cl¯ to N distances of 3.252 and 
3.245 Å. 
The effects of Cl¯ addition were also examined for acetonitrile-d3 solutions of 
[Re(CO)3(dien)]PF6 and a mixture of meso-exo and chiral [Re(CO)3(N,N′,N′′-Me3dien)]PF6. 
However, a much lower concentration of Cl¯ (20 mM) was necessary to reach the final 
downfield shifts. In this solvent, Δδ had a nearly linear dependence on Cl¯ concentration 
(Appendix C); therefore, binding constants could not be calculated. The Δδ values for the exo-
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NH signals of 1, meso-exo-4, and chiral-4 (~ 2.7, 2.4, and 2.7 ppm, respectively) in acetonitrile-
d3 were greater than in DMSO-d6 and also greater than for the central N2H signal of 
[Re(CO)3(dien)]+ and the endo-NH signal of chiral-4 (Δδ ~ 1.3 and 1.4 ppm, respectively, in 
acetonitrile-d3). The final "absolute" chemical shift values of these signals were similar in both 
DMSO-d6 and acetonitrile-d3. This latter finding, combined with the observed larger Δδ values 
and apparently much larger binding constants for acetonitrile-d3, can be explained by the weaker 
hydrogen bonding of this solvent, an acetonitrile-d3 property which allows better competition for 
the NH by Cl¯ and which leads to a lower initial chemical shift for the NH signals. 
 
 
Figure 4.6. Space-filling model of 1a showing the orientation of the exo-NH’s and endo-NH’s 
relative to the pocket formed by the ethylene chains of dien. Also shown (right) is the proposed 
positioning of the Cl¯ ion for H-bonding between the exo-NH’s.  
 
To understand these interactions better, we examined dien complexes with the ligand 
coordinated in a meridional fashion. The 1H NMR spectrum of [Pt(dien)Cl]Cl (DMSO-d6, 5 
mM) exhibits two sets of three NH signals each: an upfield set for [Pt(dien)Cl]+ and a downfield 
set for [Pt(dien)(Me2SO-d6)]2+.29 Upon Cl¯ (~ 100 mM) addition to a such a solution, the 
[Pt(dien)(Me2SO)]2+ NH signals shifted downfield (from 6.43 and 6.52 ppm to 6.78 and 6.86 
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ppm, respectively, for the terminal NH2 groups and from 7.10 to 8.66 ppm (Δδ ~ 1.6 ppm) for 
the central NH group). In contrast, for [Pt(dien)Cl]+, the two terminal NH2 signals (5.43 and 5.51 
ppm) did not change, and only the central NH signal shifted (from 7.10 to 7.78 ppm, Δδ ~ 0.7 
ppm). The X-ray structure of [Pt(dien)Cl]Cl (meridional coordination of dien), (unpublished 
data) suggests that the central NH is somewhat shielded from the solvent by the two ethylene 
chains (cf. figure in Appendix C). Consequently, the central NH is not readily available to form 
H-bonds with DMSO-d6. Upon Cl¯ addition, we believe that the obstructed central NH forms H-
bonds with the relatively small Cl¯ ion (vs. the bulkier DMSO-d6). In contrast, analysis of the X-
ray structure of fac-[Re(CO)3(dien)]+ suggests that the central NH will be relatively exposed to 
the solvent (the two ethylene chains project away from the central NH, cf. figure in Appendix C). 
Thus, the central NH is available for H-bonding with the solvent, disfavoring interaction with the 
Cl¯ ion. The insignificant change in chemical shift of the terminal NH2 signals in [Pt(dien)Cl]+ is 
attributed to the presence of the chloro ligand creating a localized negatively charged region 
inhibiting Cl¯ ion interaction near the terminal NH2 groups. Also, in [Pt(dien)(Me2SO)]2+ the 
bulky Me2SO ligand prevents strong interaction of the Cl¯ ion with the terminal NH2 groups. 
Thus, contrary to what is observed for the fac-[Re(CO)3L] complexes, interaction of Cl¯ ion at 
the central NH group of Pt(dien) complexes is more favorable than at the terminal amines.  
From the locations of both the endo- and exo-NH protons of the terminal amine of the 
different fac-[Re(CO)3L] structures, we believe that the exo-NH's are somewhat protected from 
the solvent, whereas the endo-NH's seem to be more exposed to the solvent. Space-filling models 
of the X-ray structures show that the exo-NH points slightly toward the pocket formed by the 
ethylene chains of L (Figure 4.6). In contrast, the endo-NH, which points toward the carbonyl 
ligands and away from any L bulk, appears to be more exposed to the solvent. The X-ray 
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structure of [Pt(dien)Cl]Cl (unpublished data) indicates that the exo and endo NH protons should 
have a similar exposure to solvent, explaining the much smaller difference in the chemical shift 
of the two NH signals compared to the difference observed for fac-[Re(CO)3L] complexes.  
4.4 Conclusions 
The simple prototypical ligands studied here bind to the fac-Re(CO)3 core in tridentate 
mode, giving cations of the fac-[Re(CO)3L]+ type. Most complexes reported here have the same 
chirality in each chelate ring, a finding in accord with our observation that less severe steric 
clashes between rings would occur when both rings have the same chirality. However, our results 
are surprisingly in contrast in the light of literature surveys, which show that complexes of the 
fac-M(dien) type with different chirality occur more often. An interesting finding was the 
downfield shifting of the exo-NH’s of the meso-exo-[Re(CO)3(N,N′,N′′-Me3dien)]PF6 complex 
upon addition of base. This effect might be caused by the formation of a hydroxo/water solvation 
bridge between the two exo-NH’s, which probably are in a relatively fixed position in this meso-
exo isomer. Addition of Cl¯ caused downfield shifting of the relatively upfield exo-NH’s of 
[Re(CO)3(dien)]+ and two isomers of [Re(CO)3(N,N′,N′′-Me3dien)]+, suggesting that hydrogen 
bonding occurs between the exo-NH’s and the Cl¯ ion. This finding indicates that the exo-NH’s 
are protected from the solvent environment and therefore have relatively upfield chemical shifts 
compared to the endo-NH’s. The interactions of the various ligand groups in tracer metal 
complexes influence biodistribution and must be understood in order to improve methods of 
targeting such tracers. NMR methods are among the best approaches for assessing interactions of 
tracer complexes in solution. The types of analysis that we have presented can be viewed as 
being in their infancies. Some of the unusual and as yet incompletely explained NMR shifts of 
Re analogues of 99mTc tracers very probably reflect differences in solvation of the various parts 
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of the bound ligands. We believe that more investigations of this type will be needed for rational 
design of tracers. 
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CHAPTER 5. CONCLUSIONS 
 
In general the sulfonamide ligands proved to be excellent ligands for both the Pt(II) and 
fac-Re(CO)3 metal centers. The DNSH-dienH ligand can act as a bidentate, tridentate, or 
quadridentate ligand in Pt(II) complexes, and the tmbSO2-dien and tmbSO2-dipn ligands can act 
as bidentate or tridentate in fac-[Re(CO)3L] complexes. In general high pH is necessary for the 
sulfonamide group to deprotonate and bind to the metal center, whereas in low pHs only the 
amine groups of the tridentate ligand bind.  
We achieved the synthesis of a new Pt(II) complex, Pt(DNSH-dien)Cl, which increases 
the reactivity toward 5′-GMP relative to that toward met. Therefore, such a complex might act as 
a model for the development of a new class of Pt(II) drugs with lower reactivity toward S-
containing biomolecules and consequently less toxicity than cisplatin. 
The sulfonamido group in the fac-[Re(CO)3L] (L = sulfonamide ligands) complexes can 
act as a potential anchor for bioconjugation, while giving complexes with neutral net charge, 
indicating that this class of tridentate ligands should be useful in the development of 
radiopharmaceuticals with a 99mTc(CO)3 label.  
The NMR investigation of fac-[Re(CO)3L] complexes with the simple NNN and NSN 
prototypical ligands provided insight into the basis of the existence of one unusual NH signal in 
several fac-[Re(CO)3L] complexes with terminal amino groups. We were able to assign the 
relatively upfield NH signal to the exo-NH proton and we believe that this unusual upfield 
chemical shift might be attributed to its limited exposure to the solvent environment.  
 91
APPENDIX A. fac-[Re(CO)3L] COMPLEXES CONTAINING TRIDENTATE 
MONOANIONIC LIGANDS (L¯) HAVING A TERMINAL AMIDO AND TWO AMINE 
LIGATING GROUPS* 
 
A.1 Introduction 
Technetium-99m (99mTc) is the most widely used diagnostic radionuclide in nuclear 
medicine.1-4 The [99mTc(V)O]3+ core has been used most predominantly, but recently the 
development of the advantageous [99mTc(CO)3(H2O)3]+ precursor has opened new directions for 
radiolabeling.5-7 Schibli et al. showed that agents with the fac-99mTc(I)(CO)3+ core bearing a 
tridentate coordinated ligand are more robust and have better pharmacokinetic profiles than 
agents bearing bidentate ligands.8 Frequently used chelating ligands contain N, O, or S donor 
atoms in groups such as carboxyls,9 amines,10,11 nitrogen heterocycles,12 and thioethers.13,14 A 
neutral metal-containing label is most useful in the development of small (~5 kDa) metal nuclide 
radiopharmaceuticals for bioconjugation to hormones, small peptides, etc. because such neutral 
labels are most likely to preserve the biological properties of the tagged species.15 Complexes 
made from the non-radioactive fac-[Re(CO)3(H2O)3]+ analogue of fac-[99mTc(CO)3(H2O)3]+ 
generally provide the necessary background to define the chemistry of the 99mTc agents.13 A 
neutral labeling unit can best be achieved by using monoanionic tridentate ligands.  The most 
common negative donor, the carboxyl group, does not allow bioconjugation, however. We 
recently reported a series of fac-[Re(CO)3(NNN)] complexes of monoanionic tridentate ligands 
with three nitrogen donors (NNN) containing the seldom-used sulfonamido group.16 In the 
names of the NNN ligands (LH) used here (cf. caption of Figure 4.1), the H’s designate the 
sulfonamide and amide NH proton that is absent in the facially coordinated deprotonated bound 
                                                 
* Submitted to the Journal of Chemical Crystallography: Christoforou, A. M., Marzilli, P. A., 
Fronczek, F. R., Marzilli, L. G., "fac-Re(CO)3L Containing Tridentate Monoanionic Ligands 
(L¯) Having a Termianl Amido Group and Two Amine Ligating Groups" 
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L¯. The sulfonamido group offers diverse chemistry and allows bioconjugation through the 
terminal ligating group. The amido group is very commonly used in bioconjugation chemistry 
because of its significance in peptides. Although the amido group has been widely used as a 
ligating group in M(V)O3+ radiopharmaceuticals, 17 very little use of this group has been made 
for fac-99mTc(I)(CO)3 agents, especially as a terminal ligating group.18 Herein, we describe the 
fac-[Re(CO)3L] complexes formed by fac-[Re(CO)3(H2O)3]+ with tmbCO-N,N-Me2dienH and 
tmbCO-dienH, containing the monoanionic deprotonated amido ligand bound in a tridentate 
fashion. Because all compounds described herein have a facial arrangement of the three 
carbonyls, hereafter the fac designation will be used only in referring to general types of 
compounds and will be omitted when referring to specific compounds. 
 
Figure A.1. Ligands used in this study: N-[2-(2-dimethylaminoethylamino)-ethyl]-2,4,6-
trimethylbenzamide (tmbCO-N,N-Me2dienH); and N-[2-(2-aminoethylamino)-ethyl]-2,4,6-
trimethylbenzamide (tmbCO-dienH) and ligands referred to in the text: N-[2-(2-
dimethylaminoethylamino)-ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-N,N-Me2dienH) 
and N-[2-(2-aminoethylamino)-ethyl]-2,4,6-trimethylbenzenesulfonamide (tmbSO2-dienH). The 
H’s in the ligand names designate a sulfonamide/amide proton lost upon Re binding. 
 
In fac-[99mTc(CO)3L] agents, the bioconjugation emanates from an atom of one chelate 
ring of the tridentate ligand. Because chelate ring atoms act as a fulcrum, the configuration of 
asymmetric centers, the shape, and the conformation of the rings can have a large effect on the 
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overall shape of the agent, and hence on its biological activity. Therefore, it is clearly important 
to understand how the ligand pucker depends on the various components that can influence it 
(donor atoms, chains linking these atoms, exocyclic substituents, etc.).  
Although chelate ring pucker and factors affecting pucker have not been thoroughly 
examined for radiopharmaceuticals, extensive structural information exists for a large number of 
complexes with other metals containing chelate rings with an ethylene group bridge between 
ligating atoms. Many of these structures have been analyzed by using principal component 
analysis (pca) and other methods.19-26 When diethylenetriamine-type ligands bind to a metal 
center in a tridentate fashion, the two five-membered chelate rings can have either δ or λ 
chirality (Chart 1), leading to four possible combinations of chelate ring chirality: δλ, λδ, λλ and 
δδ.  
Chart A.1 
 
Pca studies on X-ray structures from the Cambridge Structural Database (CSD) of 
M(dien) structures19-21 showed that the δλ and λδ conformation combinations were found much 
more frequently than those with the λλ and δδ pucker chirality.  
A.2 Experimental Section 
A.2.1 Starting Materials.  N,N-dimethyldiethylenetriamine (N,N-Me2dien) from Ames 
Laboratories, 2,4,6-trimethylbenzoyl chloride (tmbCOCl) from Alfa Aesar, diethylenetramine 
(dien) and Re2(CO)10 from Aldrich were all used as received. The [Re(CO)3(H2O)3]OTf13 (OTf = 
trifluoromethanesulfonate) precursor was prepared by known methods. 
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A.2.2 NMR Spectroscopy.  1H NMR spectra were recorded on either a 300 MHz or 400 
MHz spectrometer. Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference.  All NMR data were processed with XWINNMR and Mestre-C software. 
A.2.3 X-ray Data Collection and Structure Determination. All single crystals suitable 
for X-ray crystallography were obtained by slow evaporation from acetone or methanol. Single 
crystals were placed in a cooled nitrogen gas stream at 90 K on a Nonius Kappa CCD 
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα 
(0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan method, 
with HKL SCALEPACK.27 All X-ray structures were solved by direct methods and difference 
Fourier techniques and refined by full-matrix least squares techniques using SHELXL97.28 All 
non-hydrogen atoms were refined anisotropically. All hydrogen atoms were visible in difference 
maps, but were placed in idealized positions. A torsional parameter was refined for each methyl 
group.  
A.2.4 Synthesis of fac-[Re(CO)3L]. The crude ligands, LH, were synthesized by a slight 
modification of Krapcho’s method.29 A solution of the acyl chloride (tmbCOCl) (~5 mmol, 100 
mL of dioxane) was added dropwise over the course of about 2 h to a solution of the amine (~50 
mmol, 100 mL of dioxane). The reaction mixture was stirred at RT for 10 h. The dioxane was 
completely removed under vacuum, and water (50 mL) was added. The product was extracted 
into CH2Cl2 (2 × 100 mL), and the solvent was removed under rotary evaporation. The oil thus 
obtained was used to synthesize the fac-[Re(CO)3L] complexes as follows: an aqueous solution 
of [Re(CO)3(H2O)3]+ (10 mL, 0.1 mmol) was treated with a methanol (5 mL) solution of the 
ligand (0.1 mmol). The pH was adjusted to ~5 and the reaction mixture was heated at reflux for 
10 h, then allowed to cool at RT, and the pH was increased to ~ 7. The resulting white solid that 
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precipitated was collected on a filter, washed with water, and dried under vacuum. This 
procedure succeeded with LH having an amide group, but the procedure was less reliable than 
for the analogues with the sulfonamide group. 
A.2.4.1 [Re(CO)3(tmbCO-N,N-Me2dien)] (1). The general method, with 1 g of 
tmbSO2Cl and 6 mL of N,N-Me2dien, afforded the crude tmbCO-N,N-Me2dienH ligand (650 mg, 
45% yield). 1H NMR (ppm) in CDCl3: 6.82 (s, 2H), 6.50 (b, 1H, NH), 3.52 (t, 2H, CH2), 2.84 (t, 
2H, CH2), 2.68 (t,2H, CH2), 2.35 (t, 2H, CH2), 2.29 (s, 3H, CH3), 2.26 (s, 6H, CH3), 2.28 (s, 3H, 
CH3), 2.15 (s, 6H, NCH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with tmbCO-N,N-
Me2dienH (27 mg) as described above afforded [Re(CO)3(tmbCO-N,N-Me2dien)] as a white 
powder, (12 mg, 22% yield). Crystals obtained by slow evaporation from acetone were 
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6: 
6.78 (s, 1H), 6.75 (s, 1H), 6.14 (b, 1H, N2H), 3.47 (m, 1H, CH2), 3.25 (m, 3H, CH2), 3.12 (m, 
2H, CH2), 3.12 (s, 3H, NCH3), 2.97 (s, 3H, NCH3), 2.87 (m, 2H, CH2), 2.21 (s, 3H, CH3), 2.18 
(s, 3H, CH3), 2.13 (s, 3H, CH3). 
A.2.4.2 [Re(CO)3(tmbCO-dien)] (2). The general method, with tmbCOCl (1 g) and dien 
(5 mL), yielded the crude tmbCO-dienH ligand (650 mg, 45% yield). 1H NMR (ppm) in CDCl3: 
6.80 (s, 2H), 6.27 (b, 1H, NH), 3.53 (t, 2H, CH2), 2.85 (t, 2H, CH2), 2.77 (t,2H, CH2), 2.67 (t, 
2H, CH2), 2.28 (s, 3H, CH3), 2.26 (s, 6H, CH3). Treatment of [Re(CO)3(H2O)3]+ (0.1 mmol) with 
tmbCO-NMe2dienH (25 mg) as described above afforded [Re(CO)3(tmbCO-NMe2dien)] as a 
white powder (15 mg, 29% yield). Crystals obtained by slow evaporation from acetone were 
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) spectrum in acetone-d6: 
6.79 (s, 1H), 6.75 (s, 1H), 6.16 (b, 1H, N2H), 4.86 (b, 1H, N1H), 4.52 (b, 1H, N1H), 3.31 (m, 
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1H, CH2), 3.16 (m, 1H, CH2), 3.08-2.94 (m, 5H, CH2), 2.67 (m, 1H, CH2), 2.20 (s, 3H, CH3), 
2.18 (s, 6H, CH3).  
A.3 Results and Discussion 
A.3.1 X-Ray Characterization. Both complexes reported here (Figure A.2) have a 
distorted octahedral structure, with the three carbonyl ligands coordinated facially. The 
remaining coordination sites are occupied by two sp3 N amines and one sp2 N from an amido 
group. Typically, the Re−C(3) bonds, involving the CO group trans to the amido group, are not 
different from those of the other Re−CO bonds or the respective Re−C(3) bonds of the relevant 
sulfonamido complexes.16 Crystal data and structural refinement details are summarized in Table 
A.1 for 1 and 2. Although we found that the aromatic rings facilitated our efforts to obtain 
crystals, these rings generally were not stacked.   
 
 
Figure A.2. Perspective drawings of the S configuration of [Re(CO)3(tmbCO-N,N-Me2dien)] (1) 
and [Re(CO)3(tmbCO-dien)] (2). Thermal ellipsoids are drawn with 50% probability.   
 
A.3.2 Bond Lengths and Bite Angles. The average Re−N bond length of ~2.2 Å (Table 
A.2) found in the amido complexes is consistent with distances found in relevant fac-
[Re(CO)3L] complexes.11,14,16 The Re−N1 bond (N1Me2 group) in [Re(CO)3(tmbCO-N,N-
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Me2dien)] (1) is longer than the other Re−N bonds of 1 and 2. This lengthening is attributed to 
the bulkiness of the two methyl groups on N1 (for 1) compared to the smaller H group in 2. 
Similar results, were observed for the respective bonds of fac-[Re(CO)3L] (L = tmb-sulfonamido 
ligands) complexes. 
Table A.1. Crystal Data and Structural Refinement for [Re(CO)3(tmbCO-N,N-Me2dien)] (1), and 
[Re(CO)3(tmbCO-dien)] (2) 
 fac-[Re(CO)3L] complex 
 1 2 
empirical formula C19H26N3O4Re C17H22N3O4Re•H2O 
fw 546.63 536.59 
crystal system monoclinic monoclinic 
space group P21/c C2/c 
a (Å) 19.5793 (15) 36.861 (7) 
b (Å) 7.4239 (5) 7.3990 (10) 
c (Å) 14.8071 (10) 14.933 (3) 
β (°) 104.425 (5) 102.145 (8) 
V (Å3) 2084.4 (3) 3981.6 (12) 
T (K) 90 90 
Z 4 8 
ρcalc (mg/m3) 1.742 1.790 
μ (mm-1) 5.857 6.135 
transm. coeff. 0.387-0.474 0.373-0.837 
2θmax (°) 73.8 65.2 
R indicesa 0.027 0.032 
wR2 = [I> 2σ(I)]b 0.060 0.077 
data/param 9895/253 7003/245 
resid. dens. (Å-3) 1.39, -2.14 1.78, -1.88 
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Table A.2. Selected Bond and Atom Distances (Å) and Angles (deg) for [Re(CO)3(tmbCO-N,N-
Me2dien)] (1), and [Re(CO)3(tmbCO-dien)] (2) 
fac-[Re(CO)3L] complex 
 1 2 
bond distances 
Re–N1 2.2738 (19) 2.216 (3)
Re–N2 2.2087 (19) 2.207 (3)
Re–N3 2.1744 (17) 2.185 (3)
bond angles 
N1–Re–N2 79.37 (7) 77.87 (10)
N2–Re–N3 76.10 (7) 74.26 (10)
N1–Re–N3 85.81 (7) 90.16 (10)
N2–Re–C2 172.33 (9) 170.10 (13)
non-bonded distances 
N1 to N2 2.863 2.779
N2 to N3 2.702 2.651
C4 to C7 3.308 4.169
C4H to C7H 2.299 4.621
C5 to C6 2.510 2.468
C5H to C6H 2.283 2.586
 
It is known that the sp2 N donors can form shorter Re−N bonds than the sp3 N donors.12,30 
The Re−N3 sp2 bond of the amido group in both 1 and 2 is statistically shorter than the 
respective Re−N1 and Re−N2 bonds (which are Re−sp3N bonds). The shorter Re−N3 sp2 bond 
compared to the Re−N sp3 bonds was also observed in similar fac-[Re(CO)3L] (L = tmb-
sulfonamido ligands) complexes.16 The effect of the hybridized sp2 N3 should also be seen in the 
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N3−C7 bond. Indeed, the N3−C7 bond is numerically (but not significantly) shorter than the 
other sp3 N−C bonds (N1−C4, N2−C5, and N2−C6). Typical Re−sp2 N bond lengths range from 
2.14 to 2.18 Å, as measured in a several Re structures containing Re−N bonds (aromatic sp2 N, 
e.g., in pyridyl ligands), whereas a typical Re−sp3 N bond length is ~2.2 Å.12-14 The sp2 
hybridized N3 should affect the C−N3−C7, C−N3−Re, and C7−N3−Re angles. However, the 
differences between molecules, while generally consistent with expectations for Re−sp2 N vs. 
Re−sp3 N centers, are small and thus are masked by steric and solid state effects. The N−Re−N 
bite angles in the amido complexes are between 74.2 and 79.3°. The N2−Re−N3 bite angle (ring 
containing the amido group) is smaller (~75°) than the N1−Re−N2 bite angle (~78°), as found 
for the related angles in fac-[Re(CO)3L] (L = tmb-sulfonamido ligands) complexes.16 The N1 to 
N2 and N2 to N3 non-bonded distances within five-membered chelate rings in 1 and 2 have a 
narrow range of values (Table A.2) and are similar to those of relevant fac-[Re(CO)3L] 
complexes,16 as well as those of complexes with higher valent metal centers.31  
A.3.3 Chelate Ring Chirality. As mentioned in the Introduction, chelate ring shape and 
conformation affect the overall shape of the bioconjugated agent. In accordance with other 
relevant compounds,20,21 and our findings for fac-[Re(CO)3L] sulfonamido complexes,16 1 has 
different chirality in each ring pucker; λδ for the S configuration at Re (The Re configuration is 
S for structures shown in Figure A.2).16 In contrast, both chelate rings have the same chirality in 
complex 2 (both δ for the S configuration), a finding we attribute to two strong intermolecular 
hydrogen bonds from the NH2 to two waters of crystallization (N…O 2.924(4) at x,y,z and 
2.941(4) Å at 1-x, 1-y, 1-z). The fact that complex 2 has the same chirality in both rings is an 
unusual but not unprecedented finding.16,19-21 The non-bonded distances between the chelate 
rings agree with our previous study16 finding that C5 to C6 (Table A.2) and C5H to C6H 
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distances are not very different whether the pucker chirality of the two chelate rings is the same 
or different, whereas the C4 to C7 and C4H to C7H distances (cf. Figure A.2 for the atom 
numbering) are larger than when the chirality is different. 
We compared the position of the pendant group and the shape and chirality of the ring pucker 
of complex 1 with its relevant sulfonamido complex.16 An overlay of the structure of complex 1 
and the [Re(CO)3(tmbSO2-N,N-Me2dien)] complex (Figure A.3) illustrates that even though the 
dien backbone of the ligand has a very good fit, the location of the pendant tmb group is 
significantly different. These comparisons indicate that the change from an amido to a 
sulfonamido ligating group does not affect the backbone structure, but the change in the nature of 
the linkage of the tmb group to the coordinated nitrogen influences the position of the pendant 
group. 
                                  
Figure A.3. Overlay of the [Re(CO)3(tmbCO-N,N-Me2dien)] (red) and [Re(CO)3(tmbSO2-N,N-
Me2dien)] (blue) complexes (RMS = 0.026 Å from overlaying the Re, N1, N2, and N3 atoms). 
 
A.3.4 Trimethylbenzyl Group Rotation. In the X-ray structures of 1 and 2 (Figure A.2), 
the 3 and 5 protons and the 2 and 6 methyl groups of the tmbSO2 group are not equivalent. 
Indeed, in the 1H NMR spectra of complexes 1 and 2, the signals of the magnetically 
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inequivalent two aromatic protons and two methyl groups of the tmbCO group have similar 
shifts (see Experimental Section) but are fully resolved. The signals do not merge when the 
spectrum in acetone-d6 is recorded at 40 °C. In contrast, for fac-[Re(CO)3L] complexes with a 
sulfonamido group instead of an amido group, these signals are combined for the aromatic and 
for the methyl protons, indicating fast rotation on the NMR time scale.16  
 
 
Figure A.4. Two views illustrating the possible steric clashes leading to restricted rotation 
around the C (amido group)−C (tmb group) bond for 2.   
 
In the X-ray structures of 1 and 2, the amido N3−C−O group is planar. Therefore, it can 
adopt only two orientations with the oxygen facing away or towards the coordination face; in 
both orientations serious clashes are observed when the tmb group is rotated around the 
C−C(tmb) bond (with the help of modeling software). The conformer with the oxygen facing 
towards the coordination face seems to be unfavorable because the tmb group is placed very 
close to the carbonyl group and rotation of the tmb group would overlap with the carbonyl group. 
In the second conformer (which is observed in the X-ray structures of 1 and 2) clashes of the 
methyl group (of tmb) with the ethylene chain of dien appear to hinder rotation around the 
C(amido)−C(tmb) bond. Similar clashes were observed also in the relevant fac-[Re(CO)3L] (L = 
tmb-sulfonamido complexes) compexes16 during rotation the around the C(sulfonamido)−C(tmb) 
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bond. The sulfonamido group S atom is part of longer bonds (N−S and S−C) bonds and a more 
acute N3−S−C angle compared to the respective bonds (N3−C ~1.32 Å and C−C ~1.51 Å) and 
angle (N3−C−C ~120°) of the amido group in the [Re(CO)3(tmbCO-dien)] and [Re(CO)3(N,N-
Me2tmbCO-dien)] complexes. The equivalence of the tmb signals of the sulfonamido complexes 
despite the inequivalence in the X-ray structure16 was attributed to the relatively faster rotation of 
the tmb group about the S(sulfonamido)−C(tmb) bond of the sulfonamido group compared to the 
C(amido)−C(tmb) bond of the amido group,32 and that synchronous rotations about the longer 
N−S and S−C bonds can explain the relatively free rotation of the tmb group for sulfonamido 
complexes.16 We believe that for the fac-[Re(CO)3L] amido complexes (1 and 2) the 
combination of the presence of only one favorable conformer, the short bonds and slow rotation 
of the amido group result in hindered rotation around the C(amido)−C (tmb) bond, from clashes 
of the methyl group (of tmb) with the ethylene chain (Figure A.4). 
A.3.5 NMR Characterization of [Re(CO)3L] (L¯ = tmbCO-N,N-Me2dien¯ and 
tmbCO-dien¯). The fac-[Re(CO)3L] complexes were characterized by NMR spectroscopy in 
DMSO-d6, as well as in acetone-d6 (Table A.3). The [Re(CO)3(tmbCO-dien)] (2) complex has a 
terminal NH2 group with one NH exo and one NH endo to the tricarbonyl face, which give rise 
to a relatively upfield exo-NH signal (3.94 ppm) and a relatively downfield endo-NH signal (4.99 
ppm) in DMSO-d6. These shifts (Table A.3) are roughly comparable to those for the terminal 
NH2 group of relevant fac-[Re(CO)3L] (L¯ = tmb-sulfonamido ligands) complexes (3.30 to 3.54 
ppm for upfield NH signal and 5.21 to 5.26 ppm for downfield NH signal).16 The exo-NH signal 
of [Re(CO)3(tmbSO2-dien)] is ~0.5 ppm more upfield compared to that of 2, a difference that 
might be attributed to the different distance of the exo-NH protons to the nearest oxygens of the 
sulfonamido/amido group. The distance of the exo-NH of 2 to the oxygen of the CO group is 3.5 
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Å, whereas the respective distance for the [Re(CO)3(tmbSO2-dien)] complex is 2.8 Å.  The 
explanation for the relatively upfield shift of the exo-NH signal is unclear, but such a signal 
appears to be a general finding for fac-[Re(CO)3L] complexes with an exo-NH group. One 
possibility is that steric effects obstruct formation of H-bonds with the solvent and therefore the 
downfield shift effect of NH H-bonding to solvent is decreased. 
 
Table A.3. Selected Chemical Shifts (ppm) of [Re(CO)3(tmbCO-N,N-Me2dien)] (1), and 
[Re(CO)3(tmbCO-dien)] (2) 
 1 2 
DMSO-d6 
exo-N1H/Me 2.79 3.94 
endo-N1H/Me 3.02 4.99 
N2H 6.72 6.69 
acetone-d6 
exo-N1H/Me 2.97 4.53 
endo-N1H/Me 3.12 4.86 
N2H 6.14 6.17 
 
A.4 Conclusions 
In our studies we find that the fac-[Re(CO)3L] amido complexes are much more difficult 
to synthesize, compared to the related sulfonamido complexes, consistent with the scarcity of 
related amido complexes in the literature. An inner coordination sphere with a neutral charge is 
achieved upon binding of the tridentate monoanionic amido ligands in the fac-[Re(CO)3(NNN)] 
complexes studied here. The dangling tmb group connected through the amido bond experiences 
hindered rotation on the NMR time scale, due to the rigidity of the amido group (compared to the 
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more flexible sulfonamido group). Complex 1 has different chirality in each chelate ring, as 
commonly found in the literature, whereas complex 2 has same chirality in each chelate ring.  
The pendant tmb group has very different positions in [Re(CO)3(tmbCO-N,N-Me2dien)] and 
[Re(CO)3(tmbSO2-N,N-Me2dien)]. Therefore, the different linker components (CO and SO2) lead 
to different overall shapes. 
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APPENDIX B. SUPPLEMENTARY MATERIAL FOR CHAPTER 3 
B.1 Synthesis and Crystal Data and Structural Refinement for Re(CO)3(DNS-dien)1 
B.1.1 Synthesis of Re(CO)3(DNS-dien) (4). Treatment of 0.1 mmol of 
[Re(CO)3(H2O)3]+ with 33.2 mg of DNS-dienH2 as described for Re(CO)3L afforded 
Re(CO)3(DNS-dien) as a white powder (35 mg, 58% yield). Crystals obtained by slow 
evaporation from methanol were characterized by single-crystal X-ray crystallography. 1H NMR 
spectrum (acetone-d6) (ppm): 8.66 (d, 1H), 8.40 (d, 1H), 8.12 (d, 1H), 7.49 (q, 2H), 7.20 (d, 1H), 
6.23 (b, 1H, N1H), 4.77 (b, 1H, N1H), 4.09 (b, 1H, N1H), 3.67 (m, 1H, CH2), 3.32-2.94 (m, 5H, 
CH2), 2.92 (m, 1H, CH2), 2.85 (s, 6H, CH3). 
 
 
 
Figure B.1. Perspective drawings of the S configuration of Re(CO)3(DNS-dien) (4).1 Thermal 
ellipsoids are drawn with 50% probability. 
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Figure B.2. Orientation of the SO2 group in complexes 1-4. 
Table B.1. Crystal Data and Structural Refinement for Re(CO)3(DNSH-dien) (4) 
 Re(CO)3(DNSH-dien)  Re(CO)3(DNSH-dien) 
empirical 
formula 
C19H23N4O5ReS γ (°) 90.0 
fw 605.67 V (Å3) 2164.8 (8) 
crystal system monoclinic T (K) 110 
space group P21/c Z 4 
unit cell 
dimensions 
 ρcalc (g/cm3) 1.858 
a (Å) 12.527 (3) abs coeff (mm-1) 5.748 
b (Å) 13.934 (3) 2θmax (°) 61 
c (Å) 12.603 (2) R indicesa 0.036 
α (°) 90.0 wR2 = [I> 2σ(I)]b 0.082 
β (°) 100.249 (9) data/param 6591/273 
 
aR = (∑||Fο| - |Fc||)/∑|Fο|; bwR2 = [∑[w(Fο2 - Fc2)2]/∑[w(Fο2)2]]1/2 
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B.2 Comparison of Metric Information and Structural Features of Complexes 1-5 
B.2.1 Distances of the ethylene chain carbons to the N−Re−N plane. The distances 
between the carbons of the ethylene chains to the N−Re−N plane are listed in Table 3. For 
complexes 1-4 in the sulfonamido-containing ring both C6 and C7 are below (away from the 
triangular face of L¯) the N2−Re−N3 plane (Figure 4). In contrast, in the terminal amine ring C4 
is above and C5 is below the N1−Re−N2 plane for complexes 1-3. In 4, C5 is also below the 
plane but C4 is almost in the N1−Re−N2 plane (Table S2, Figure 4) 
Table B.2. Distances of Ethylene Chain Carbons to the N–Re–N Plane (Sign Denotes if the C is 
Above (Positive) and Toward the Ligand Coordinated Face or Below (Negative) and Away From 
the Ligand Trigonal Face) 
Re(CO)3L complex 
 1 2 3 4 
C4 to N1–Re–N2 0.526/0.546 0.462 0.375 -0.026 
C5 to N1–Re–N2 -0.104/-0.074 -0.145 -0.251 -0.652 
C6 to N2–Re–N3 -0.750/-0.771 -0.697 -0.683 -0.294 
C7 to N2–Re–N3 -0.249/-0.235 -0.148 -0.125 -0.836 
 
Table B.3. Selected Torsion Angles (deg) for complexes 2-5 Used to Assign the NH2 1H NMR 
Signals 
Re(CO)3L complex 
 2 3 4 5 
H1B–N1–C4–H4A 41.5 39.0 25.9 56.2 
H1B–N1–C4–H4B 77.5 80.2 92.7 173.9 
H1A–N1–C4–H4A 159.8 157.0 143.1 58.1 
H1A–N1–C4–H4B 40.6 37.69 24.5 59.6 
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Figure B.3. Drawing of Re(CO)3L, showing the torsion angle between N1H and C4H. 
 
B.3 IR Spectroscopy. 
The IR spectra of acetone solutions of complexes 1-5 exhibit three bands attributed to CO 
stretching of the fac-Re(CO)3 moiety (Table S4); a sharp, strong band in the 2010-2027 cm-1 
region and two broad bands in the 1860-1920-cm-1 region. These values are in a similar range of 
those of relevant Re(CO)3 complexes containing amine chelate ligands3 as well those of the 
[Re(CO)3(NH3)3]+ complex.4 
 
Table B.4. CO-stretching Absorptions (cm-1)in the IR Spectra of Acetone Solutions of 1-5 
Re(CO)3L complex 
1 2 3 4 5 
2015 2027 2019 2010 2010 
1907 1920 1906 1888 1889 
1877 1884 1883 1875 1860 
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APPENDIX C. SUPPLEMENTARY MATERIAL FOR CHAPTER 4 
 
 
 
Figure C.1. Change in chemical shift (Δδ) of exo-NH, endo-NH and N2H signals of 
[Re(CO)3(dien)]PF6 upon addition of Cl¯ in acetonitrile-d3. 
 
 
 
Figure C.2. Change in chemical shift (Δδ) of exo-NH signal of meso-exo-4 and exo-NH and 
endo-NH signals of chiral-4 upon addition of Cl¯ in acetontrile-d3. 
 
 113
 
 
Figure C.3. Change in chemical shift (Δδ) of exo-NH and endo-NH signals of 
[Re(CO)3(daes)]PF6 upon addition of Cl¯ in DMSO-d6. 
 
 
 
 
 
Figure C.4. Change in chemical shift (Δδ) of exo-NH signal of meso-exo-4 and exo-NH and 
endo-NH signals of chiral-4 upon addition of Cl¯ in DMSO-d6. 
         
 114
                                        
Figure C.5. Overlay illustration of complexes 6 (red) and 2 (blue) (RMS value = 0.125 from 
overlaying the Re, N1, N2/S, and N2/N3 atoms). The N2-CH3 group of 2 is omitted for clarity. 
 
 
 
 
 
Figure C.6. Orientation of central NH in [Pt(dien)Cl]Cl (left) and Re(CO)3(dien)]PF6 (right). 
Counter ions are omitted for clarity. 
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Figure C.7. 1H-1H COSY NMR spectrum of meso-exo-4 and chiral-4 (mixture obtained upon 
isomerization with base) in DMSO-d6/0.04 M NaOH, 600 µL/10 µL. 
S5 
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APPENDIX D. CRYSTALLOGRAPHC AND SPECTROSCOPIC DATA FOR 
MISCELLANIOUS PLATINUM(II)-SULFONAMIDO COMPLEXES 
 
Two types of ligands based on 2-aminopyridine (2-amp), diethylenetriamine (dien) or 
ethylenediamine (en) with a 2,4,6-trimethylbenzoyl (tmbSO2) or methyl (CH3) group through a 
sulfonamide group were used in this study. Treatment of cis-Pt(Me2SO)2Cl2 with the 
sulfonamide ligands gave the neutral complexes Pt(2-ampSO2CH3)(Me2SO)Cl, Pt(2-
ampSO2tmb)(Me2SO)Cl, Pt(tmbSO2-en)(Me2SO)Cl, and Pt(tmbSO2-N,N-Me2dien)Cl. X-ray 
crystallographic and NMR analyses confirm that in both the solid and solution states the ligands 
based on 2-amp or en are bound to Pt(II) in a bidentate fashion with the sulfonamido group 
being deprotonated. The coordination sphere is completed with a Cl ligand (trans to the 
sulfonamido N) and a Me2SO ligand (trans to the pyridine N).  The tmbSO2-N,N-Me2dienH 
ligand is bound in tridentate fashion with the sulfonamido group being deprotonated. 
D.1 Experimental Section 
D.1.1 Starting Materials.  2-aminomethylpyridine, methanesulfonyl chloride 
(CH3SO2Cl) and 2-mesitylenesulfonyl chloride (tmbSO2Cl) from Aldrich were all used as 
received. cis-Pt(Me2SO)2Cl2, tmbSO2-N,N-Me2dien and tmbSO2-en were synthesized as 
described elsewhere.1,2 
D.1.2 NMR Spectroscopy.  1H NMR spectra were recorded on either a 300 MHz or 400 
MHz spectrometer.  Peak positions are relative to TMS or solvent residual peak, with TMS as 
reference.  All NMR data were processed with XWINNMR and Mestre-C software. 
D.1.3 X-ray Data Collection and Structure Determination. All single crystals suitable 
for X-ray crystallography were obtained by slow evaporation from acetone or methanol. Single 
crystals were placed in a cooled nitrogen gas stream at ~100 K on a Nonius Kappa CCD 
diffractometer fitted with an Oxford Cryostream cooler with graphite-monochromated Mo Kα 
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(0.71073 Å) radiation. Data reduction included absorption corrections by the multi-scan method, 
with HKL SCALEPACK.3 All X-ray structures were determined by direct methods and 
difference Fourier techniques and refined by full-matrix least squares techniques, by using 
SHELXL97.4 All non-hydrogen atoms were refined anisotropically. All hydrogen atoms were 
visible in difference maps, but were placed in idealized positions. A torsional parameter was 
refined for each methyl group. Mercury Software was used for measuring torsion angles. 
D.2 Pt(II) Complexes of 2-Aminopyridine-Sulfonamide Ligands. 
D.2.1 Synthesis of 2-ampSO2R (R = CH3 or tmb) 
A solution of the sulfonyl chloride (tmbSO2Cl or CH3SO2Cl) (~5 mmol, 100 mL of 
dioxane) was added dropwise over the course of about 0.5 h to a solution of 2-amp (~10 mmol, 
100 mL of dioxane). The reaction mixture was stirred at RT overnight. A white solid was present 
in the reaction mixture at the end of the reaction. The dioxane was completely removed under 
vacuum, and water (50 mL) was added. The product was extracted into CH2Cl2 (2 × 100 mL), 
and the solvent was removed under rotary evaporation. The oil thus obtained was used to 
synthesize the Pt(2-ampSO2R)(Me2SO)Cl complexes as follows.  
D.2.1.1 Synthesis of 2-ampSO2CH3 (1). The general method, with CH3COCl (0.56 g) 
and 2-amp (1.08 g), yielded the 2-ampSO2CH3 ligand (1.18 g, 65% yield). Crystals obtained 
from CDCl3 were characterized by single-crystal X-ray crystallography. 1H NMR (ppm) in 
CDCl3: 8.56 (d, 1H), 7.73 (t, 1H), 7.36 (t, 1H), 7.26 (d, 1H), 6.13 (b, 1H, NH), 4.47 (d, 2H, CH2), 
2.91 (s, 3H, CH3). 
D.2.1.2 Synthesis of 2-ampSO2tmb (2). The general method, with tmbCOCl (1.02 g) 
and 2-amp (1.08 g), yielded the 2-ampSO2CH3 ligand (1.68 mg, 58 % yield). Crystals obtained 
from slow evaporation of a CH2Cl2 solution were characterized by single-crystal X-ray 
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crystallography 1H NMR (ppm) in CDCl3: 8.47 (d, 1H), 7.56 (t, 1H), 7.15 (m, 2H), 6.89 (s, 2H, 
tmb), 6.00 (b, 1H, NH), 4.16 (d, 2H, CH2), 2.67 (s, 6H, CH3), 2.26 (s, 3H, CH3). 
D.2.2 Synthesis of Pt(2-ampSO2R)(Me2SO)Cl (R = CH3 or tmb) 
A methanol solution (20 mL) of cis-Pt(Me2SO)2Cl2 (0.5 mmol) and 2-ampSO2R (R = 
CH3 or tmb) (0.5 mmol) in the presence of triethylamine (500 µL) was heated at 60 °C for 2 h. 
The reaction mixture was allowed to stir at RT overnight. The yellow solid that precipitated was 
collected, washed with diethyl ether and dried in vacuo. 
D.2.2.1 Synthesis of Pt(2-ampSO2CH3)(Me2SO)Cl (3). Treatment of cis-Pt(Me2SO)2Cl2 
(0.211 g) with 2-ampSO2CH3 (146 mg) afforded Pt(2-ampSO2CH3)(Me2SO)Cl (158 mg, 52 % 
yield) as a yellow solid. Crystals obtained from slow evaporation of the reaction filtrate were 
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) in DMSO-d6: 8.92 (d, 
1H), 8.15 (t, 1H), 7.80 (d, 1H), 7.59 (t, 1H), 4.56 (d, 2H, CH2), 2.59 (s, 3H, CH3). 
D.2.2.2 Synthesis of Pt(2-ampSO2tmb)(Me2SO)Cl (4). Treatment of cis-Pt(Me2SO)2Cl2 
(0.211 g) with 2-ampSO2CH3 (94 mg) afforded Pt(2-ampSO2CH3)(Me2SO)Cl (114 mg, 46 % 
yield) as a yellow solid. Crystals obtained from slow evaporation of the reaction filtrate were 
characterized by single-crystal X-ray crystallography. 1H NMR (ppm) in DMSO-d6: 8.61 (d, 
1H), 7.91 (t, 1H), 7.58 (d, 1H), 7.36 (t, 1H), 6.73 (s, 2H, tmb), 4.36 (d, 2H, CH2), 2.73 (s, 6H, 
tmb-CH3), 2.08 (s, 3H, tmb-CH3). 
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Figure D.1. Perspective drawing of 2-ampSO2CH3 (1). Thermal ellipsoids are drawn with 50% 
probability. 
 
 
 
Figure D.2. Perspective drawing of 2-ampSO2CH3 (2). Hydrogen bonds observed in solid state 
are depicted. Thermal ellipsoids are drawn with 50% probability. 
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Figure D.3. Perspective drawings of Pt(2-ampSO2CH3)(Me2SO)Cl (3) and Pt(2-
ampSO2tmb)(Me2SO)Cl (4). Thermal ellipsoids are drawn with 50% probability. 
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Table D.1. Crystal Data and Structural Refinement for 2-ampSO2CH3 (1), 2-ampSO2tmb (2), 
Pt(2-ampSO2CH3)(Me2SO)Cl (3), and Pt(2-ampSO2tmb)(Me2SO)Cl (4) 
 1 2 3 4 
Chemical formula C7H10N2O2S⋅
HCl 
C15H18N2O2S C9H15ClN2O3PtS2 C17H23ClN2O3PtS2
⋅CH4O 
Mr 222.69 290.37 493.89 630.08 
Cell setting  
space group 
Monoclinic  
P21/c 
Monoclinic  
P21/c 
Monoclinic  
P21/c 
Monoclinic 
P21/n 
Temperature (K) 110 100 90 115 
a(Å) 
b(Å) 
c (Å) 
7.332 (2) 
14.067 (4) 
9.474 (3) 
13.6863 (15) 
11.5328 (12) 
18.838 (2) 
14.7137 (17)  
8.6927 (10) 
10.5988 (15) 
9.2130 (10)  
21.591 (3) 
11.1716 (15) 
β (°) 91.898 (11) 104.933 (4) 98.935 (7) 100.777 (7) 
V (Å3) 976.6 (5) 2873.0 (5) 1339.2 (3) 2183.0 (5) 
Z 4 8 4 4 
Dx (Mg m–3) 1.515 1.343 2.450 1.917 
µ (mm–1) 0.57 0.23 10.99 6.77 
No. of measured, 
independent and 
observed reflections 
18808, 2972, 
2403 
46928, 10432, 
8039 
30404, 5269, 
4819 
30100, 6696, 5494
Rint 0.028 0.025 0.021 0.033 
θmax (°) 30.5 32.6 33.7 30.8 
R[F2 > 2s(F2)], 
wR(F2), S 
0.036, 0.081, 
1.06 
0.043, 0.110, 
1.02 
0.026, 0.064, 1.09 0.058, 0.136, 1.24
No. of relections 2972 
reflections 
10432 reflections 5269 reflections 6696 reflections 
No. of parameters 125 374 167 259 
(Δ/σ)max 0.001 0.001 0.003 0.002 
Δρmax, Δρmin (e Å–3) 0.42, –0.43 0.43, –0.45 1.58, –2.49 3.91, –3.93 
Extinction 
coefficient 
  0.0007 (2) 0.00150 (13)   
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Table D.2. Selected Bond and Atom Distances (Å) and Angles (deg) for Pt(2-
ampSO2CH3)(Me2SO)Cl (3) and Pt(2-ampSO2tmb)(Me2SO)Cl (4). 
 3 4 
bond distances 
Pt–N1 2.045 (3) 2.058 (7) 
Pt–N2 2.029 (3) 2.039 (7) 
bond angles 
N1–Pt–N2 80.85 (11) 80.9 (3) 
N1–Re–S 172.86 (8) 173.8 (2) 
N1–Re–Cl 94.68 (8) 93.1 (2) 
 
D.3 Pt(II) Complexes of Ethylenediamine- and Diethylenetriamine-Sulfonamide Ligands  
D.3.1 Synthesis of Pt(tmbSO2-N,N-Me2dien)Cl (5).  
A methanol solution (20 mL) of cis-Pt(Me2SO)2Cl2 (0.5 mmol, 211 mg) was treated with 
tmbSO2-N,N-Me2dien (0.5 mmol, 156 mg) in the presence of triethylamine (500 µL). The 
reaction mixture was allowed to stir at RT overnight. The yellow solid that precipitated was 
collected, washed with diethyl ether and dried in vacuo; yield, 132 mg (48 %) Crystals obtained 
from slow evaporation of the reaction filtrate were characterized by single-crystal X-ray 
crystallography. 1H NMR (ppm) in DMSO-d6: 6.88 (s, 2H), 6.61 (b, NH), 3.03 (m, 4H, CH2), 
2.84 (m, 4H, CH2), 2.81 (s, 3H, CH3), 2.73 (s, 3H, CH3), 2.73 (s, 6H, CH3), 2.19 (s, 3H, CH3). 
D.3.2 Synthesis of Pt(tmbSO2-en)(Me2SO)Cl (6). 
A methanol solution (20 mL) of cis-Pt(Me2SO)2Cl2 (0.25 mmol, 105 mg) was treated 
with tmbSO2-en (0.25 mmol, 61 mg) in the presence of triethylamine (500 µL). The reaction 
mixture was allowed to stir at RT overnight. The yellow solid that precipitated was collected, 
washed with diethyl ether and dried in vacuo; yield, 57 mg (42 %). Crystals obtained upon 
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addition of acetronitrile to the reaction filtrate were characterized by single-crystal X-ray 
crystallography. 1H NMR (ppm) in DMSO-d6: 6.95 (s, 2H), 5.77 (s, 2H), 2.76 (b, 2H, CH2), 2.72 
(s, 6H, CH3), 2.23 (s, 3H, CH3), 2.01 (b, 2H, CH2). 
 
Table D.3. Crystal Data and Structural Refinement for Pt(tmbSO2-N,N-Me2dien)Cl (5) and 
Pt(tmbSO2-en)(Me2SO)Cl (6) 
 5 6 
Chemical formula C15H26ClN3O2PtS C13H23ClN2O3PtS2 
Mr 542.99 549.99 
Cell setting 
 space group 
Monoclinic 
 P21/c 
Monoclinic 
 P21/c 
Temperature (K) 90 90 
a (Å) 
b (Å) 
c (Å) 
15.075 (3) 
13.191 (3) 
9.6030 (15) 
19.7581 (15)  
7.5133 (5)  
11.8480 (10) 
β (°) 105.167 (13) 91.003 (5) 
V (Å3) 1843.1 (6) 1758.5 (2) 
Z 4 4 
Dx (Mg m–3) 1.957 2.077 
μ (mm–1) 7.88 8.38 
No. of measured, 
independent and observed 
reflections 
26111, 6660, 4340 54939, 11293, 9138 
Rint 0.057 0.025 
θmax (°) 32.6 41.4 
R[F2 > 2σ(F2)], wR(F2), S 0.044, 0.093, 1.03 0.030, 0.075, 1.06 
No. of relections 6660 reflections 11293 reflections 
No. of parameters 212 205 
(Δ/σ)max 0.001 0.002 
Δρmax, Δρmin (e Å–3) 4.01, –2.09 2.41, –3.00 
Extinction coefficient 0.00053 (11) 0.00213 (13) 
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Figure D.4. Perspective drawings of Pt(tmbSO2-N,N-Me2dien)Cl (5). Thermal ellipsoids are 
drawn with 50% probability. 
 
 
 
 
 
Figure D.5. Perspective drawings of Pt(tmbSO2-en)(Me2SO)Cl (6). Thermal ellipsoids are 
drawn with 50% probability. 
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